<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/30A429E3-83B7-4E41-99C0-14A144F07DFE"><gtr:id>30A429E3-83B7-4E41-99C0-14A144F07DFE</gtr:id><gtr:name>University of Southampton</gtr:name><gtr:address><gtr:line1>Administration Building</gtr:line1><gtr:line2>Highfield</gtr:line2><gtr:line4>Southampton</gtr:line4><gtr:line5>Hampshire</gtr:line5><gtr:postCode>SO17 1BJ</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/3A5E126D-C175-4730-9B7B-E6D8CF447F83"><gtr:id>3A5E126D-C175-4730-9B7B-E6D8CF447F83</gtr:id><gtr:name>University College London</gtr:name><gtr:address><gtr:line1>Gower Street</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>WC1E 6BT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/D35F3544-BE4C-432D-9A90-D8E58B4A2023"><gtr:id>D35F3544-BE4C-432D-9A90-D8E58B4A2023</gtr:id><gtr:name>Selcia</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/C81341B0-BEB1-46A2-B6CA-9EED6B183AE0"><gtr:id>C81341B0-BEB1-46A2-B6CA-9EED6B183AE0</gtr:id><gtr:name>University of Bari Aldo Moro</gtr:name><gtr:address><gtr:line1>Piazza Umberto I, 1</gtr:line1><gtr:region>Outside UK</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/0B92D4B2-4955-4E0E-A0B8-2511FE3C2422"><gtr:id>0B92D4B2-4955-4E0E-A0B8-2511FE3C2422</gtr:id><gtr:name>Koninklijke Philips Electronics N.V.</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/102F2A51-71E4-4ECA-A245-9B9C4858D7E4"><gtr:id>102F2A51-71E4-4ECA-A245-9B9C4858D7E4</gtr:id><gtr:name>MRC Harwell</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/403AB155-4169-4425-850E-4019D864C3C1"><gtr:id>403AB155-4169-4425-850E-4019D864C3C1</gtr:id><gtr:name>Imperial College London Diabetes Centre</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/A1382653-9660-42B5-8658-B7FBD06F5D06"><gtr:id>A1382653-9660-42B5-8658-B7FBD06F5D06</gtr:id><gtr:name>AstraZeneca plc</gtr:name><gtr:address><gtr:line1>2 Kingdom Street</gtr:line1><gtr:postCode>W2 6BD</gtr:postCode><gtr:region>London</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/E3241676-C5F4-44EA-938D-E6C6EF8C4E50"><gtr:id>E3241676-C5F4-44EA-938D-E6C6EF8C4E50</gtr:id><gtr:name>Unilever R&amp;D Vlaardingen B.V.</gtr:name><gtr:address><gtr:line1>Unilever Research</gtr:line1><gtr:line2>Laboratory</gtr:line2><gtr:line3>Olivier Van Noortlaan 120</gtr:line3><gtr:postCode>NL-3133 AT</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Netherlands</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/3B1E5961-8677-4A32-B15C-12FB968FA163"><gtr:id>3B1E5961-8677-4A32-B15C-12FB968FA163</gtr:id><gtr:name>University of Pennsylvania</gtr:name><gtr:address><gtr:line1>3451 Walnut Street,</gtr:line1><gtr:line2>Suite P-221</gtr:line2><gtr:line3>Franklin Building</gtr:line3><gtr:line4>Philadelphia</gtr:line4><gtr:postCode>PA 19104</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/75E77BF3-29B4-4699-9CD9-223230E8A463"><gtr:id>75E77BF3-29B4-4699-9CD9-223230E8A463</gtr:id><gtr:name>Babraham Institute</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/20FDE301-787F-433E-A102-D64CC1EF3508"><gtr:id>20FDE301-787F-433E-A102-D64CC1EF3508</gtr:id><gtr:name>University of Cagliari</gtr:name><gtr:address><gtr:line1>Piazza d'Armi - 09123</gtr:line1><gtr:line4>Cagliari</gtr:line4><gtr:postCode>09123</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Italy</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/03D8AFBB-3EA5-4885-B036-BD4F9F4F9849"><gtr:id>03D8AFBB-3EA5-4885-B036-BD4F9F4F9849</gtr:id><gtr:name>University of Sheffield</gtr:name><gtr:address><gtr:line1>Firth Court</gtr:line1><gtr:line2>Western Bank</gtr:line2><gtr:line4>Sheffield</gtr:line4><gtr:line5>South Yorkshire</gtr:line5><gtr:postCode>S10 2TN</gtr:postCode><gtr:region>Yorkshire and The Humber</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/E6756F63-3FA1-4DD9-8FFB-67C6EB0C4E90"><gtr:id>E6756F63-3FA1-4DD9-8FFB-67C6EB0C4E90</gtr:id><gtr:name>Pennsylvania State University</gtr:name><gtr:address><gtr:line1>110 Technology Center Building</gtr:line1><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/FF66505C-CECD-4483-8FDA-E8347F32AF9E"><gtr:id>FF66505C-CECD-4483-8FDA-E8347F32AF9E</gtr:id><gtr:name>King's College Hospital Charity</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/AE6EAB1A-CC2F-4FDB-A57F-41E76D78ACAB"><gtr:id>AE6EAB1A-CC2F-4FDB-A57F-41E76D78ACAB</gtr:id><gtr:name>Oxford University Hospitals NHS Trust</gtr:name><gtr:address><gtr:line1>Churchill Site</gtr:line1><gtr:line2>Old Road</gtr:line2><gtr:line3>Headington</gtr:line3><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX3 7LJ</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/20E66A18-4A43-4DD5-BA98-5320F6EC9269"><gtr:id>20E66A18-4A43-4DD5-BA98-5320F6EC9269</gtr:id><gtr:name>GlaxoSmithKline (GSK)</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/798EE1A4-3D20-4DF0-A6CD-E6F6C2E22598"><gtr:id>798EE1A4-3D20-4DF0-A6CD-E6F6C2E22598</gtr:id><gtr:name>Agilent Technologies UK Ltd</gtr:name><gtr:address><gtr:line1>610 Wharfedale Road</gtr:line1><gtr:line2>IQ Winnersh</gtr:line2><gtr:postCode>RG41 5TP</gtr:postCode><gtr:region>South East</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/589909BD-8284-4811-BDF4-8A05F9B6E222"><gtr:id>589909BD-8284-4811-BDF4-8A05F9B6E222</gtr:id><gtr:name>Institute for Cancer Research (Istituto di Candiolo IRCCS)</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/04500B3A-1219-4E25-96B6-5AFBA5839CAA"><gtr:id>04500B3A-1219-4E25-96B6-5AFBA5839CAA</gtr:id><gtr:name>French National Institute of Agricultural Research</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/D1774113-D5D2-4B7C-A412-66A90FE4B96F"><gtr:id>D1774113-D5D2-4B7C-A412-66A90FE4B96F</gtr:id><gtr:name>University of Cambridge</gtr:name><gtr:address><gtr:line1>Lensfield Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 1EW</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/78308CAA-8483-45C0-A280-0AB4B6AD9D35"><gtr:id>78308CAA-8483-45C0-A280-0AB4B6AD9D35</gtr:id><gtr:name>Medical Research Council</gtr:name><gtr:address><gtr:line1>Polaris House</gtr:line1><gtr:line2>North Star Avenue</gtr:line2><gtr:postCode>SN2 1FL</gtr:postCode><gtr:region>South West</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/961756BF-E31F-4A13-836F-0A09BA02385C"><gtr:id>961756BF-E31F-4A13-836F-0A09BA02385C</gtr:id><gtr:name>University of Exeter</gtr:name><gtr:address><gtr:line1>University of Exeter</gtr:line1><gtr:line2>Clydesdale House</gtr:line2><gtr:line3>Clydesdale Road</gtr:line3><gtr:line4>Exeter</gtr:line4><gtr:postCode>EX4 4QX</gtr:postCode><gtr:region>South West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/5EE55E7A-9A75-4570-A04D-D9F36C3129EC"><gtr:id>5EE55E7A-9A75-4570-A04D-D9F36C3129EC</gtr:id><gtr:name>National Institutes of Health</gtr:name><gtr:address><gtr:line1>31 Center Drive</gtr:line1><gtr:line2>9000 Rockville Pike</gtr:line2><gtr:postCode>20892</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/A861D5B4-C006-49D3-8DF9-5C184B00E4AC"><gtr:id>A861D5B4-C006-49D3-8DF9-5C184B00E4AC</gtr:id><gtr:name>Kenyan Institute for Medical Research (KEMRI)</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/BE5027A2-9A29-4322-AB89-41E0AF3BC9FF"><gtr:id>BE5027A2-9A29-4322-AB89-41E0AF3BC9FF</gtr:id><gtr:name>MedImmune</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/FB2338E9-0BA1-474F-BC1B-5482C6EDAEC1"><gtr:id>FB2338E9-0BA1-474F-BC1B-5482C6EDAEC1</gtr:id><gtr:name>Biocrates Life Sciences</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/4E55B119-02E7-43F3-9B39-DD48A6511372"><gtr:id>4E55B119-02E7-43F3-9B39-DD48A6511372</gtr:id><gtr:name>Addenbrooke's Hospital</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/2CB28F86-3C05-48F2-8953-38DC15EAAEA9"><gtr:id>2CB28F86-3C05-48F2-8953-38DC15EAAEA9</gtr:id><gtr:name>Syrris</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/9A22541F-DA58-481E-8D0C-C4BCF4EA030E"><gtr:id>9A22541F-DA58-481E-8D0C-C4BCF4EA030E</gtr:id><gtr:name>EMBL - European Bioinformatics Institute</gtr:name><gtr:address><gtr:line1>Wellcome Trust Genome Campus</gtr:line1><gtr:line2>Hinxton</gtr:line2><gtr:line4>Cambridge</gtr:line4><gtr:line5>Cambridgeshire</gtr:line5><gtr:postCode>CB10 1SD</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/39387A8B-DE6F-4056-865E-3013C290FC4E"><gtr:id>39387A8B-DE6F-4056-865E-3013C290FC4E</gtr:id><gtr:name>MRC Human Nutrition Research Group</gtr:name><gtr:address><gtr:line1>MRC Human Nutrition Research Group</gtr:line1><gtr:line2>Medical Research Council (HQ)</gtr:line2><gtr:line3>Elsie Widdowson laboratory Fulbourn Road</gtr:line3><gtr:postCode>CB1 9NL</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/39387A8B-DE6F-4056-865E-3013C290FC4E"><gtr:id>39387A8B-DE6F-4056-865E-3013C290FC4E</gtr:id><gtr:name>MRC Human Nutrition Research Group</gtr:name><gtr:address><gtr:line1>MRC Human Nutrition Research Group</gtr:line1><gtr:line2>Medical Research Council (HQ)</gtr:line2><gtr:line3>Elsie Widdowson laboratory Fulbourn Road</gtr:line3><gtr:postCode>CB1 9NL</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/30A429E3-83B7-4E41-99C0-14A144F07DFE"><gtr:id>30A429E3-83B7-4E41-99C0-14A144F07DFE</gtr:id><gtr:name>University of Southampton</gtr:name><gtr:address><gtr:line1>Administration Building</gtr:line1><gtr:line2>Highfield</gtr:line2><gtr:line4>Southampton</gtr:line4><gtr:line5>Hampshire</gtr:line5><gtr:postCode>SO17 1BJ</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/3A5E126D-C175-4730-9B7B-E6D8CF447F83"><gtr:id>3A5E126D-C175-4730-9B7B-E6D8CF447F83</gtr:id><gtr:name>University College London</gtr:name><gtr:address><gtr:line1>Gower Street</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>WC1E 6BT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/D35F3544-BE4C-432D-9A90-D8E58B4A2023"><gtr:id>D35F3544-BE4C-432D-9A90-D8E58B4A2023</gtr:id><gtr:name>Selcia</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/C81341B0-BEB1-46A2-B6CA-9EED6B183AE0"><gtr:id>C81341B0-BEB1-46A2-B6CA-9EED6B183AE0</gtr:id><gtr:name>University of Bari Aldo Moro</gtr:name><gtr:address><gtr:line1>Piazza Umberto I, 1</gtr:line1><gtr:region>Outside UK</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/0B92D4B2-4955-4E0E-A0B8-2511FE3C2422"><gtr:id>0B92D4B2-4955-4E0E-A0B8-2511FE3C2422</gtr:id><gtr:name>Koninklijke Philips Electronics N.V.</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/102F2A51-71E4-4ECA-A245-9B9C4858D7E4"><gtr:id>102F2A51-71E4-4ECA-A245-9B9C4858D7E4</gtr:id><gtr:name>MRC Harwell</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/403AB155-4169-4425-850E-4019D864C3C1"><gtr:id>403AB155-4169-4425-850E-4019D864C3C1</gtr:id><gtr:name>Imperial College London Diabetes Centre</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/A1382653-9660-42B5-8658-B7FBD06F5D06"><gtr:id>A1382653-9660-42B5-8658-B7FBD06F5D06</gtr:id><gtr:name>AstraZeneca plc</gtr:name><gtr:address><gtr:line1>2 Kingdom Street</gtr:line1><gtr:postCode>W2 6BD</gtr:postCode><gtr:region>London</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/E3241676-C5F4-44EA-938D-E6C6EF8C4E50"><gtr:id>E3241676-C5F4-44EA-938D-E6C6EF8C4E50</gtr:id><gtr:name>Unilever R&amp;D Vlaardingen B.V.</gtr:name><gtr:address><gtr:line1>Unilever Research</gtr:line1><gtr:line2>Laboratory</gtr:line2><gtr:line3>Olivier Van Noortlaan 120</gtr:line3><gtr:postCode>NL-3133 AT</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Netherlands</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/3B1E5961-8677-4A32-B15C-12FB968FA163"><gtr:id>3B1E5961-8677-4A32-B15C-12FB968FA163</gtr:id><gtr:name>University of Pennsylvania</gtr:name><gtr:address><gtr:line1>3451 Walnut Street,</gtr:line1><gtr:line2>Suite P-221</gtr:line2><gtr:line3>Franklin Building</gtr:line3><gtr:line4>Philadelphia</gtr:line4><gtr:postCode>PA 19104</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/75E77BF3-29B4-4699-9CD9-223230E8A463"><gtr:id>75E77BF3-29B4-4699-9CD9-223230E8A463</gtr:id><gtr:name>Babraham Institute</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/20FDE301-787F-433E-A102-D64CC1EF3508"><gtr:id>20FDE301-787F-433E-A102-D64CC1EF3508</gtr:id><gtr:name>University of Cagliari</gtr:name><gtr:address><gtr:line1>Piazza d'Armi - 09123</gtr:line1><gtr:line4>Cagliari</gtr:line4><gtr:postCode>09123</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Italy</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/03D8AFBB-3EA5-4885-B036-BD4F9F4F9849"><gtr:id>03D8AFBB-3EA5-4885-B036-BD4F9F4F9849</gtr:id><gtr:name>University of Sheffield</gtr:name><gtr:address><gtr:line1>Firth Court</gtr:line1><gtr:line2>Western Bank</gtr:line2><gtr:line4>Sheffield</gtr:line4><gtr:line5>South Yorkshire</gtr:line5><gtr:postCode>S10 2TN</gtr:postCode><gtr:region>Yorkshire and The Humber</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/E6756F63-3FA1-4DD9-8FFB-67C6EB0C4E90"><gtr:id>E6756F63-3FA1-4DD9-8FFB-67C6EB0C4E90</gtr:id><gtr:name>Pennsylvania State University</gtr:name><gtr:address><gtr:line1>110 Technology Center Building</gtr:line1><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/FF66505C-CECD-4483-8FDA-E8347F32AF9E"><gtr:id>FF66505C-CECD-4483-8FDA-E8347F32AF9E</gtr:id><gtr:name>King's College Hospital Charity</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/AE6EAB1A-CC2F-4FDB-A57F-41E76D78ACAB"><gtr:id>AE6EAB1A-CC2F-4FDB-A57F-41E76D78ACAB</gtr:id><gtr:name>Oxford University Hospitals NHS Trust</gtr:name><gtr:address><gtr:line1>Churchill Site</gtr:line1><gtr:line2>Old Road</gtr:line2><gtr:line3>Headington</gtr:line3><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX3 7LJ</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/20E66A18-4A43-4DD5-BA98-5320F6EC9269"><gtr:id>20E66A18-4A43-4DD5-BA98-5320F6EC9269</gtr:id><gtr:name>GlaxoSmithKline (GSK)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/798EE1A4-3D20-4DF0-A6CD-E6F6C2E22598"><gtr:id>798EE1A4-3D20-4DF0-A6CD-E6F6C2E22598</gtr:id><gtr:name>Agilent Technologies UK Ltd</gtr:name><gtr:address><gtr:line1>610 Wharfedale Road</gtr:line1><gtr:line2>IQ Winnersh</gtr:line2><gtr:postCode>RG41 5TP</gtr:postCode><gtr:region>South East</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/589909BD-8284-4811-BDF4-8A05F9B6E222"><gtr:id>589909BD-8284-4811-BDF4-8A05F9B6E222</gtr:id><gtr:name>Institute for Cancer Research (Istituto di Candiolo IRCCS)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/04500B3A-1219-4E25-96B6-5AFBA5839CAA"><gtr:id>04500B3A-1219-4E25-96B6-5AFBA5839CAA</gtr:id><gtr:name>French National Institute of Agricultural Research</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/D1774113-D5D2-4B7C-A412-66A90FE4B96F"><gtr:id>D1774113-D5D2-4B7C-A412-66A90FE4B96F</gtr:id><gtr:name>University of Cambridge</gtr:name><gtr:address><gtr:line1>Lensfield Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 1EW</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/78308CAA-8483-45C0-A280-0AB4B6AD9D35"><gtr:id>78308CAA-8483-45C0-A280-0AB4B6AD9D35</gtr:id><gtr:name>Medical Research Council</gtr:name><gtr:address><gtr:line1>Polaris House</gtr:line1><gtr:line2>North Star Avenue</gtr:line2><gtr:postCode>SN2 1FL</gtr:postCode><gtr:region>South West</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/961756BF-E31F-4A13-836F-0A09BA02385C"><gtr:id>961756BF-E31F-4A13-836F-0A09BA02385C</gtr:id><gtr:name>University of Exeter</gtr:name><gtr:address><gtr:line1>University of Exeter</gtr:line1><gtr:line2>Clydesdale House</gtr:line2><gtr:line3>Clydesdale Road</gtr:line3><gtr:line4>Exeter</gtr:line4><gtr:postCode>EX4 4QX</gtr:postCode><gtr:region>South West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/5EE55E7A-9A75-4570-A04D-D9F36C3129EC"><gtr:id>5EE55E7A-9A75-4570-A04D-D9F36C3129EC</gtr:id><gtr:name>National Institutes of Health</gtr:name><gtr:address><gtr:line1>31 Center Drive</gtr:line1><gtr:line2>9000 Rockville Pike</gtr:line2><gtr:postCode>20892</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/A861D5B4-C006-49D3-8DF9-5C184B00E4AC"><gtr:id>A861D5B4-C006-49D3-8DF9-5C184B00E4AC</gtr:id><gtr:name>Kenyan Institute for Medical Research (KEMRI)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/BE5027A2-9A29-4322-AB89-41E0AF3BC9FF"><gtr:id>BE5027A2-9A29-4322-AB89-41E0AF3BC9FF</gtr:id><gtr:name>MedImmune</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/FB2338E9-0BA1-474F-BC1B-5482C6EDAEC1"><gtr:id>FB2338E9-0BA1-474F-BC1B-5482C6EDAEC1</gtr:id><gtr:name>Biocrates Life Sciences</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/4E55B119-02E7-43F3-9B39-DD48A6511372"><gtr:id>4E55B119-02E7-43F3-9B39-DD48A6511372</gtr:id><gtr:name>Addenbrooke's Hospital</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/2CB28F86-3C05-48F2-8953-38DC15EAAEA9"><gtr:id>2CB28F86-3C05-48F2-8953-38DC15EAAEA9</gtr:id><gtr:name>Syrris</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/9A22541F-DA58-481E-8D0C-C4BCF4EA030E"><gtr:id>9A22541F-DA58-481E-8D0C-C4BCF4EA030E</gtr:id><gtr:name>EMBL - European Bioinformatics Institute</gtr:name><gtr:address><gtr:line1>Wellcome Trust Genome Campus</gtr:line1><gtr:line2>Hinxton</gtr:line2><gtr:line4>Cambridge</gtr:line4><gtr:line5>Cambridgeshire</gtr:line5><gtr:postCode>CB10 1SD</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/7B37377E-AAF0-4C32-BA3D-0395632DCBB7"><gtr:id>7B37377E-AAF0-4C32-BA3D-0395632DCBB7</gtr:id><gtr:firstName>Julian</gtr:firstName><gtr:otherNames>Leether</gtr:otherNames><gtr:surname>Griffin</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=MC_UP_A090_1006"><gtr:id>EFC3E53D-4230-4169-A9AE-77810E2AAFC4</gtr:id><gtr:title>Lipid Profiling and Signalling: Macronutrients and Metabolic Health</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Intramural</gtr:grantCategory><gtr:grantReference>MC_UP_A090_1006</gtr:grantReference><gtr:abstractText>According to statistics reported by Diabetes UK in 2010, since 1996 the number of people diagnosed with diabetes has increased from 1.4 million to 2.6 million, and is set to rise to four million people by 2025. The majority of these cases are associated with type 2 diabetes (T2DM), with the increased prevalence arising from an increasingly aged population and the rise in overweight and obese people. The interaction between being overweight and T2DM arises because fats become inappropriately stored in organs such as the liver, pancreas and skeletal muscle, reducing the body?s capacity to respond to the hormone insulin, an important signal which regulates the storage of nutrients. However, one central enigma concerning the interaction between obesity and T2DM is why some individuals appear to have a near limitless capacity for storing fat without proceeding to diabetes, while other appear to be pre-disposed to the disease.
The lipid profiling and signalling group are using novel mass spectrometry, nuclear magnetic resonance spectroscopy and computer aided modelling to understand this problem. We have a range of studies that investigate the effects of over-nutrition, and in particular the role that high fat intake plays in inducing disease. The benefits of this work are an improvement in our understanding of the disease process, providing new drug targets, and the identification of ?biomarkers?, molecular signatures of disease or treatment that could be used for diagnostics.</gtr:abstractText><gtr:technicalSummary>Understanding how fat metabolism is regulated in the human body is essential to understanding a number of major pathologies affecting human health including type II diabetes (T2DM), obesity, atherosclerosis and fatty liver disease. The incidence of both T2DM and obesity are rising rapidly across the globe as a result of over nutrition. The aim of the Lipid Profiling and Signalling programme is to understand why on an individual basis certain people develop insulin resistance and subsequently type 2 diabetes, while others stay metabolically healthy, and in particular how diet interacts with relative risk. We investigate the regulation of lipid metabolism and its interplay with health and diseases of over nutrition using a combination of state of the art mass spectrometry, NMR spectroscopy and bioinformatics to use an individual?s metabolism as a measure of their relative risk of developing disease. The programme consists of four inter-related areas of research.
The first involves the understanding of adipose tissue metabolism in health and disease. In particular through work on peroxisome proliferator activated receptors (PPARs), three receptors that play a central role in regulating metabolism at the whole organism level, we have investigated the regulation between lipid storage and fatty acid oxidation in this tissue. This has led us into work understanding small molecule activators of mitochondrial biogenesis in white adipose tissue, so called ?browning? agents, which could be used to reduce obesity and restore metabolic health. In addition we have developed a quantitative method for the profiling of lipid mediators, including over 100 eicosanoids and related metabolites. These mediators are important in understanding some of the mechanisms thought to mediate insulin resistance and in particular how the generation of reactive oxygen species produce lipid mediators linked to inflammation of key organs including adipose tissue.
The second area of research involves the consequences of ectopic fat deposition in liver and skeletal muscle, and how this influences insulin resistance. In addition to work in global lipidomics and eicosanoid profiling detailed above, we have also developed methods to examine how changes in fat metabolism affect the composition of sub-cellular organelles and cellular function, such as inducing endoplasmic reticulum stress and mitochondrial dysfunction. We are developing mass spectrometry tools to profile the lipid composition of sub-cellular membranes in order to understand how changes in lipid metabolism alter sub-cellular function and hence influence disease at a cellular level.
The third area of research is in molecular epidemiology. To assess the impact diet has on T2DM and the metabolic syndrome, we, in conjunction with members of MRC Epidemiology and the Institute of Public Health, University of Cambridge, are using lipidomics and metabolomics to profile individuals at the epidemiological scale and cross correlate changes in metabolism with anthropometric and genome wide association studies.
All this work is strongly underpinned by bioinformatics and multivariate statistics. We have developed a range of bioinformatic tools for the processing and storage of lipidomic data. These tools are currently being used in-house in a number of collaborative lipidomic studies into aspects of the metabolic syndrome including large scale epidemiology studies and mass spectrometry imaging of fatty liver disease.</gtr:technicalSummary><gtr:fund><gtr:end>2016-08-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2011-03-01</gtr:start><gtr:type>EXPENDITURE_ACTUAL</gtr:type><gtr:valuePounds>4586954</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>Oxford University Hospitals NHS Foundation Trust</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Collaboration on hypertrophic cardiomyopathy.</gtr:description><gtr:id>5929761F-CA02-4557-8292-FE85C31DC63C</gtr:id><gtr:impact>None to date</gtr:impact><gtr:outcomeId>DMDymX21TNQ-1</gtr:outcomeId><gtr:partnerContribution>They are providing the animal models and human tissue.</gtr:partnerContribution><gtr:piContribution>LPS has set up a collaboration to perform metabolomics and lipidomics on a study of cardiomyopathy patients with the John Radcliffe Hospital, University of Oxford. This would involve analysing blood plasma across time points from individuals with diabetes, dilated cardiomyopathy, hypertrophic cardiomyopathy and hypertension.</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Biocrates Life Sciences</gtr:collaboratingOrganisation><gtr:country>Austria, Republic of</gtr:country><gtr:description>Biocrates Collaboration on Bile Acid Analysis</gtr:description><gtr:id>A4BEA9DE-A07B-4B61-A787-BAC9F4B08302</gtr:id><gtr:impact>TBC</gtr:impact><gtr:outcomeId>546360a0a8a9e3.17651197-1</gtr:outcomeId><gtr:partnerContribution>TBC</gtr:partnerContribution><gtr:piContribution>A plate to measure 17 bile acids for 40 samples (mainly liver homogenates but can include plasma or other matrices) has been prepared by the company BIOCRATES. They have offered a 96 well plate for performing this analysis to LPS in return for LPS evaluating the performance of the method. BIOCRATES wanted the data back by the end of July. Elizabeth Stanley identified a suitable set of samples for the trial.</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Medical Research Council (MRC)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>MRC Mitochondrial Biology Unit</gtr:department><gtr:description>Monitoring reactive oxygen species damage in human patients</gtr:description><gtr:id>D85A0104-14DD-4EE3-90FC-85719BD7296F</gtr:id><gtr:impact>This collaboration has just begun.</gtr:impact><gtr:outcomeId>QFV6SfoPPgM-1</gtr:outcomeId><gtr:piContribution>We have developed assays to monitor ROS damage in liver and kidney transplant patients and in patients with selenoprotein deficiencies.</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Syrris</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Syrris collaboration to develop on-line extraction for MS analysis</gtr:description><gtr:id>ACE224AF-4872-47EA-B203-F1F4AF489EDD</gtr:id><gtr:impact>patent application for which Syrris covers the costs</gtr:impact><gtr:outcomeId>bYY4TwnRsWC-1</gtr:outcomeId><gtr:partnerContribution>Syrris provides the FLLEX technology and covers the patent application costs.</gtr:partnerContribution><gtr:piContribution>to develop technology for the combination of size exclusion chromatography with electrospray ionisation based mass spectrometry.</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>French National Institute of Agricultural Research</gtr:collaboratingOrganisation><gtr:country>France, French Republic</gtr:country><gtr:description>Collaboration with Dr St&amp;eacute;phane Hazebrouck (Laboratoire INRA d'Immuno-Allergie Alimentaire, Service de Pharmacologie et d'Immunoanalyse) &amp;amp; Dr Anne-judith Waligora-Dupriet (Universit&amp;eacute; Paris Descartes)</gtr:description><gtr:id>F36409F1-10EB-4B62-B4F5-419767E73261</gtr:id><gtr:impact>Practical work is on-going</gtr:impact><gtr:outcomeId>54636e87c7c239.22210397-1</gtr:outcomeId><gtr:partnerContribution>These groups provide samples</gtr:partnerContribution><gtr:piContribution>Collaboration with Laboratoire INRA d'Immuno-Allergie Alimentaire, Service de Pharmacologie et d'Immunoanalyse, Gif sur Yvette and Universit&amp;eacute; Paris Descartes to study the role of of the diet and gut microflora on the odd-chain fatty acid levels. Both labs have samples available. The odd-chain fatty acid containing lipids in these samples was analysed.</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>MedImmune</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>Collaboration with Medimmune</gtr:description><gtr:id>3E65EA64-CC6B-4243-BA20-7F1E34ED64C0</gtr:id><gtr:impact>None as yet</gtr:impact><gtr:outcomeId>5461da8be99624.84792317-1</gtr:outcomeId><gtr:partnerContribution>See above!</gtr:partnerContribution><gtr:piContribution>We have initated a collaboration with medimmune in terms of making our expertise and facilities in metabolomics and lipidomics available to the cardiovascular and metabolic diseases group and in return we have been offered access to their high throughput cell culture facilities, we are discussing CASE studentships and also access to previously generated mouse models of obesity and fatty liver disease.</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Bari</gtr:collaboratingOrganisation><gtr:country>Italy, Italian Republic</gtr:country><gtr:description>Lipidomics in a population eating the Mediterranean diet</gtr:description><gtr:id>6E359990-AA19-443C-991A-E3513FE0BC51</gtr:id><gtr:impact>None to date - currently processing data.</gtr:impact><gtr:outcomeId>56d81520eec7c5.32689833-1</gtr:outcomeId><gtr:partnerContribution>Providing blood plasma samples from an on-going Italian cohort</gtr:partnerContribution><gtr:piContribution>FS and MVa have established a collaboration with the University of Bari, Italy, for a project that will translate our murine studies into human research of the link between de novo lipogensis and fatty liver disease. The MTA is now in place and the University of Bari received the final approval from the ethics committee for sending the serum samples. .</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2015-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Cambridge</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Department of Paediatrics</gtr:department><gtr:description>Lipid profiling of Cambrdge Baby Growth Study Dried Blood Spot samples</gtr:description><gtr:id>91E92B84-7621-4333-BD17-287AB323BFCB</gtr:id><gtr:impact>No output yet</gtr:impact><gtr:outcomeId>TViwwKwGUkp-1</gtr:outcomeId><gtr:partnerContribution>Provide the samples, meta-data and cover cost per sample (&amp;pound;12.50 per sample). The obtained data will be analysed jointly.</gtr:partnerContribution><gtr:piContribution>CLBRI will develop and validate a method for the lipid profiling of dried blood spots on paper, based on 2.4mm diameter blood spots collected during the Cambridge Baby Browth Study.
After successful development and validation, CLBRI will analyse a pilot set (80 samples) and the full sample set (ca 800 samples) available from the Cambridhe Baby Growth Study.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Kenyan Institute for Medical Research (KEMRI)</gtr:collaboratingOrganisation><gtr:country>Kenya, Republic of</gtr:country><gtr:description>Collaboration with Centre for Public Health Research, Kenya Medical Research Institute, Nairobi, Kenya to set up a Lipids &amp;amp; Health Research group at the KEMRI</gtr:description><gtr:id>7CC039AD-C962-491A-B450-A45C9C41FEDB</gtr:id><gtr:impact>project is on-going</gtr:impact><gtr:outcomeId>54637b71ad9d90.36097692-1</gtr:outcomeId><gtr:partnerContribution>KEMRI will provide samples to analyse by LPS and will send scientists to be trained by LPS</gtr:partnerContribution><gtr:piContribution>The Centre for Public Health Research, Kenya Medical Research Institute (KEMRI), Nairobi, Kenya to help with the set-up of a lipids and health research group at the KEMRI.</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Cambridge</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Gurdon Institute</gtr:department><gtr:description>Collaboration with the Gurdon institute to follow fat metabolism in C.elegans</gtr:description><gtr:id>2FE60DCE-0496-42C1-BCAD-5E06046CBF80</gtr:id><gtr:impact>This is an on-going collaboration of JG which is now part of this new programme. It has previously brought in funding from the EU under a Marie Curie fellow and has produced two applications to the BBSRC for further funding.</gtr:impact><gtr:outcomeId>NwgATy5agor-1</gtr:outcomeId><gtr:partnerContribution>We have produced a manuscript and are currently writing another.</gtr:partnerContribution><gtr:piContribution>We are developing high throughput lipidomic methods for profiling fat metabolism in C.elegans. the aim is to understand the genetic regulation of fat metabolism at the whole genome level.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Cagliari</gtr:collaboratingOrganisation><gtr:country>Italy, Italian Republic</gtr:country><gtr:department>Department of Toxicology</gtr:department><gtr:description>Collaboration with university of Cagliari</gtr:description><gtr:id>55CDA9C9-87B7-48B2-B12A-DD3A3914C106</gtr:id><gtr:impact>A member of LPS was made a visiting professor of the university and we hosted a visiting student.</gtr:impact><gtr:outcomeId>aAW6bBRnCxu-1</gtr:outcomeId><gtr:partnerContribution>Generation of animal model and providing tissue samples</gtr:partnerContribution><gtr:piContribution>The University of Cagliari (department of Toxicology and Pathology) and LPS initiated a collaboration examining fatty liver disease by lipidomics and mass spectrometry imaging. The project is based around drug- induced fatty liver disease and how this develops into liver cancer. Cagliari would perform the animal studies and histology and LPS would provide lipidomic analysis.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Cambridge</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Department of Physiology, Development and Neuroscience</gtr:department><gtr:description>Collaboration with the Department of Physiology Development &amp;amp; Neuroscience, University of Cambridge (HNR project 6503)</gtr:description><gtr:id>67EBA33B-09F6-4B03-8821-8638B53ED6C1</gtr:id><gtr:impact>TBC</gtr:impact><gtr:outcomeId>546361be1a7810.88092486-1</gtr:outcomeId><gtr:partnerContribution>Andrew Murray's group in the Department of Physiology Development and Neuroscience, UCam oversaw the study</gtr:partnerContribution><gtr:piContribution>Liver metabolome (HNR project 6503), liver, plasma, adipose and intestine samples were collected for a mouse strain and gender comparison of the lipid and low molecular weight species of the liver metabolome (many thanks to JLG, Xinzhu Wang, LR and Frank Sanders for the sample collection.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Cambridge</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Department of Biochemistry</gtr:department><gtr:description>Collaboration with Department of Biochemistry (RF)</gtr:description><gtr:id>C691B04E-607B-45F0-B89C-58FFFDCB569A</gtr:id><gtr:impact>None as yet.</gtr:impact><gtr:outcomeId>ALP8tTm5WLr-1</gtr:outcomeId><gtr:partnerContribution>There are two grant applications under review - one to the British heart Foundation and the other to the Medical research Council</gtr:partnerContribution><gtr:piContribution>We are studying how lipids influence the role of collagen in platelet activation. In addition we are also collaborating with Prof. Wolfgang Seiss at Munich university.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Southampton</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Faculty of Medicine</gtr:department><gtr:description>Polyunsaturated fatty acid biosynthesis and vasoconstriction</gtr:description><gtr:id>8855C085-421A-4114-B7AC-7EE3F60BA2F2</gtr:id><gtr:impact>A previous manuscript.</gtr:impact><gtr:outcomeId>Bqu1WPrx8xo-1</gtr:outcomeId><gtr:partnerContribution>Main applicant and conducting the biolgical studies.</gtr:partnerContribution><gtr:piContribution>The Institute of Developmental Sciences, University of Southampton and Southampton General Hospital and LPS are applying to the BBSRC to fund a project entitled &amp;quot;Polyunsaturated fatty acid biosynthesis and vasoconstriction.&amp;quot; We have previously collaborated and published papers in this area. The project involves the analysis of eicosanoids in blood and endothelial cells/blood vessel wall.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Cambridge</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Metabolic Research Laboratories</gtr:department><gtr:description>PMMR Collaboration with MRC MRL investigating energy expenditure on patients with defective thyroid hormone transporter</gtr:description><gtr:id>317C6359-A805-4B2E-9006-0B529BB3862D</gtr:id><gtr:impact>TBC</gtr:impact><gtr:outcomeId>5463881ea52a57.08289943-1</gtr:outcomeId><gtr:partnerContribution>TBC</gtr:partnerContribution><gtr:piContribution>Edward Visser and Krish Chatterjee have approached PMMR (Michelle Venables) to collaborate on a project investigating energy expenditure in a group of patients with a defective thyroid hormone transporter (MCT8). The patients will be from a subset of a worldwide trial investigating the T3 analogue Triac. Energy expenditure will be measured before and after Triac treatment using the DLW technique. This project has been costed to cover all aspects of the study; isotope, kits, analysis and staff time. This comes to &amp;pound;12,991.78 for which he will be invoiced.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Exeter</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Stratifying type 2 diabetes - Exeter university</gtr:description><gtr:id>8F13471A-A758-4DA9-A0A4-1D87A480D5D8</gtr:id><gtr:impact>Still waiting on outcomes</gtr:impact><gtr:outcomeId>GGs2euAJ9tA-1</gtr:outcomeId><gtr:partnerContribution>Providing samples from clinical trials.</gtr:partnerContribution><gtr:piContribution>LPS has been working with various diabetes research groups around the UK as part of the MRC/BIS initiative to promote greater links between clinical research and pharmaceutical drug development. The &amp;quot;Stratifying type 2 diabetes&amp;quot; consortium, led by Prof Hattersley of Exeter University have received favourable reviews and an indication of &amp;pound;2 million funding for two clinical trails to assess drug responses to anti-diabetics and how diet, exercise and weight loss interact with drug response. The funding is subject to satisfactory responses to reviewers comments and would be considered a pilot study towards larger studies planned across five years.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Cambridge</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Cambridge Institute of Public Health</gtr:department><gtr:description>The PROMIS study</gtr:description><gtr:id>D63BCF93-7FE1-4555-A1D8-4BE235A96745</gtr:id><gtr:impact>Further funding - we have used the results to obtain further funding and perform lipidomic analysis on the EPIC heart study.</gtr:impact><gtr:outcomeId>eYAAxbEh5oo-1</gtr:outcomeId><gtr:partnerContribution>Our partners are making the samples available and also providing GWAS data to cross correlate with the lipidomic data/</gtr:partnerContribution><gtr:piContribution>We are developing a high throughput lipidomic screen for human blood plasma and this will be used to profile lipidomic changes in the PROMIS study - a epidemiology study of myocardial infarction in Pakistan.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Cambridge</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Collaboration with pathology, University of Cambridge to examine the metabolic effects of viral growth in cell culture</gtr:description><gtr:id>04DC810C-E95E-4375-87A6-E84F412CDA8D</gtr:id><gtr:impact>Publication</gtr:impact><gtr:outcomeId>5461e3687abe82.27555228-1</gtr:outcomeId><gtr:partnerContribution>See abive</gtr:partnerContribution><gtr:piContribution>We had a collaboration to look into the effects of viral growth in human cells on cell metabolism using NMR spectroscopy. This has resulted in a publication.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Biocrates Life Sciences</gtr:collaboratingOrganisation><gtr:country>Austria, Republic of</gtr:country><gtr:description>Collaboration with Biocrates to develop a kit to measure bile acids</gtr:description><gtr:id>9C25C917-ACA4-4F1D-9129-069678B801A7</gtr:id><gtr:impact>We provided feedback on the kit.</gtr:impact><gtr:outcomeId>56d8163a38b647.46774729-1</gtr:outcomeId><gtr:partnerContribution>Provided a kit they wanted us to test for bile acid measurements</gtr:partnerContribution><gtr:piContribution>We have collaborated with Biocrates, an Austrian company that develops kits for metabolomics. We have examined a Bile acid beta test kit for use with liver tissue.</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2015-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Agilent Technologies</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>Thought Leader Award from Agilent</gtr:description><gtr:id>C47868FD-290A-4125-9D42-50793DEAD302</gtr:id><gtr:impact>The collaboration starts in december 2014</gtr:impact><gtr:outcomeId>5461dbea4e1886.99008579-1</gtr:outcomeId><gtr:partnerContribution>see above.</gtr:partnerContribution><gtr:piContribution>Agilent have awarded a Thought Leader award to the head of group. This consists of a brand new ion mobility mass spectrometry plus substantial funds for research to develop this new piece of equipment. In turn we will develop new mass spectrometry tools based around ion mobility for lipid detection.</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Cambridge</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Cambridge Institute of Public Health</gtr:department><gtr:description>Lipidomics Analysis of The Interval Study</gtr:description><gtr:id>F3F44DB3-2366-4E72-ACA7-ACDAA2666A8A</gtr:id><gtr:impact>To come.</gtr:impact><gtr:outcomeId>56d8565fe4f728.40384862-1</gtr:outcomeId><gtr:partnerContribution>GWAS analysis of 50000 people.</gtr:partnerContribution><gtr:piContribution>The INTERVAL study involves the analysis of 50000 blood plasma samples from individuals giving blood and cross correlating this information with GWAS data collected by IPH. HNR will receive &amp;pound;250,000 for this work.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2015-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Penn State University</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:department>Department of Pharmacology</gtr:department><gtr:description>The liver metabolome</gtr:description><gtr:id>6ED5348C-AA60-403D-B7B6-1AF667E1E778</gtr:id><gtr:impact>This has produced a successful grant application to the NIH for funding.</gtr:impact><gtr:outcomeId>GkWKQtCBDha-1</gtr:outcomeId><gtr:partnerContribution>We are conducting animal studies together to better understand how the liver metabolome is influenced by drug and genetic intervention.</gtr:partnerContribution><gtr:piContribution>This project is a collaboration with Professor Andrew Patterson, Penn State University, USA and Dr. Frank Gonzalez, NIH, USA. This project is to develop tools in metabolomics and lipidomics. Frank Gonzalez is a group leader at NIH and developed the PPAR- alpha null mouse which we have used previously to study metabolic regulation. The purpose of this proposal is to develop workflows and bioinformatics tools for studying the liver metabolome, and in particular the impact of fatty liver and insulin resistance in the liver. While primarily focussed on mice for the first two years, subsequent years will also have a human component using tissue samples from NIH.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Addenbrooke's Hospital</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Collaboration with Transplantation Medicine, Addenbrooke's Hospital on the development of VOCs to detect Acute Kidney Injury</gtr:description><gtr:id>A147B079-DFBC-4E45-8F8B-5AD2AB3FE6B2</gtr:id><gtr:impact>work is on going</gtr:impact><gtr:outcomeId>5463715ccc49d7.50921952-1</gtr:outcomeId><gtr:partnerContribution>The Clatworthy will provide samples</gtr:partnerContribution><gtr:piContribution>Collaboration with Clatworthy group (Transplantion Medicine, Addenbrooke's &amp;amp; MRC LMB) on the development of volatile organic compounds (VOCs) in urine to detect acute kidney injury (AKI). Their aim is to use electrochemical or spectroscopic methods that could be used at the bedside. They want to use GC to validate their work and we are discussing headspace analysis to determine the VOCs of healthy people versus AKI patients. They offered to purchase the additional equipment to do headspace SPME on the Gerstel MPX systems. HNR will profile the VOCs of different patient groups.</gtr:piContribution><gtr:sector>Hospitals</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>MedImmune</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>Cambridge Metabolism Network</gtr:description><gtr:id>10E581DB-371B-4AE8-A2FB-E0C69D4FF078</gtr:id><gtr:impact>Got a CASE studentship in a multi-disciplinary research area.</gtr:impact><gtr:outcomeId>56d81ce3a1b8a6.24246837-1</gtr:outcomeId><gtr:partnerContribution>To my group they have provided a PhD studentship.</gtr:partnerContribution><gtr:piContribution>I am a member of the organising committee for the Cambridge Metabolomics Network. This has included two meetings on metabolism. The events have been sponsored by AZ, MedImmune and Novartis and contact with AZ led to a CASE pHD studentship.</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2015-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Cambridge</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Cambridge Institute of Public Health</gtr:department><gtr:description>Collaboration with CIPH to look at INTERVAL</gtr:description><gtr:id>113E4B08-1258-4178-B78A-BA007887D52C</gtr:id><gtr:impact>TBC</gtr:impact><gtr:outcomeId>54638ba214ab70.82122066-1</gtr:outcomeId><gtr:partnerContribution>TBC</gtr:partnerContribution><gtr:piContribution>Prof John Danesh (IoPH) approached Jules Griffin to set up a meeting to discuss collaborations and in particular a new venture to possibly look at INTERVAL, a 50,000-person study of very well-characterised healthy people across England in whom genomic measurements are being completed.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Imperial College London Diabetes Centre</gtr:collaboratingOrganisation><gtr:country>United Arab Emirates</gtr:country><gtr:description>Abu Dhabi Diabetes Centre Abu Dhabi, United Arab Emirtes</gtr:description><gtr:id>50FA3A96-2D38-4F3D-9FA0-B3D57C48D32B</gtr:id><gtr:impact>None to date</gtr:impact><gtr:outcomeId>HWhwUTn17sC-1</gtr:outcomeId><gtr:partnerContribution>At the moment HNR is largely providing information and assistance.</gtr:partnerContribution><gtr:piContribution>LPS has been approached by the Abu Dhabi Diabetes Centre Abu Dhabi, United Arab Emirtes, about setting up a collaboration in type 2 diabetes. This is an interesting proposal as the Gulf contains the highest incidence of type 2 diabetes in the world and they are currently performing genome wide association studies. Some metabolomics would be performed in house (amino acid analysis) but UAE are interested in running the intact lipids at MRC HNR.</gtr:piContribution><gtr:sector>Hospitals</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Southampton</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Institute of Developmental Sciences</gtr:department><gtr:description>Vascular tone and the effects of lipid mediators</gtr:description><gtr:id>B8C651DF-E0D2-4E22-B3F4-1B1F6ACAA9AA</gtr:id><gtr:impact>We have one publication under review and a grant application submitted to the BHF.</gtr:impact><gtr:outcomeId>owhNsSju6B7-1</gtr:outcomeId><gtr:partnerContribution>We have one manuscript under review and one grant application submitted to the British Heart Foundation</gtr:partnerContribution><gtr:piContribution>We are measuring lipid mediators for Southampton University to understand the role diet plays in vascular tone.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>National Institutes of Health (NIH)</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>The liver metabolome</gtr:description><gtr:id>550DF06F-1952-4511-9FB0-36D37182BAA0</gtr:id><gtr:impact>This has produced a successful grant application to the NIH for funding.</gtr:impact><gtr:outcomeId>GkWKQtCBDha-2</gtr:outcomeId><gtr:partnerContribution>We are conducting animal studies together to better understand how the liver metabolome is influenced by drug and genetic intervention.</gtr:partnerContribution><gtr:piContribution>This project is a collaboration with Professor Andrew Patterson, Penn State University, USA and Dr. Frank Gonzalez, NIH, USA. This project is to develop tools in metabolomics and lipidomics. Frank Gonzalez is a group leader at NIH and developed the PPAR- alpha null mouse which we have used previously to study metabolic regulation. The purpose of this proposal is to develop workflows and bioinformatics tools for studying the liver metabolome, and in particular the impact of fatty liver and insulin resistance in the liver. While primarily focussed on mice for the first two years, subsequent years will also have a human component using tissue samples from NIH.</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Koninklijke Philips Electronics N.V.</gtr:collaboratingOrganisation><gtr:country>Global</gtr:country><gtr:department>Philips</gtr:department><gtr:description>Philips Industrial CASE studentship</gtr:description><gtr:id>01B0D354-3E94-498C-B720-8B51DE9E757E</gtr:id><gtr:impact>This has funded a CASE studentship which will start this academic year.</gtr:impact><gtr:outcomeId>oFyqj1xNHJV-1</gtr:outcomeId><gtr:partnerContribution>The student will visit Philips to produce sensors for key biomarkers.</gtr:partnerContribution><gtr:piContribution>We are collaborating with Philips to develop electronic sensors for metabolites which may be predictive for insulin resistance or the very early stages of type II diabetes. We are providing expertise in biomarkers of type II diabetes and in return they have provided us with an EPSRC Industrial CASE studentship.</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Pennsylvania</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:department>Institute for Translational Medicine and Therapeutics (ITMAT)</gtr:department><gtr:description>GLUE grant</gtr:description><gtr:id>5EB09E8D-6B23-4A88-B9F6-0B3697E0B584</gtr:id><gtr:impact>This has led to a five year funded grant to support the work done in conjunction with the university of Cambridge.</gtr:impact><gtr:outcomeId>g5fADnXKMrt-1</gtr:outcomeId><gtr:partnerContribution>Its allowed a number of bilateral collaborations to be formed in addition to the large GLUE grant.</gtr:partnerContribution><gtr:piContribution>We are part of the analytical core to carry out metabolomics and lipidomics for an NIH GLUE grant into personalised medicine. This grant has been deemed fundable and we are awaiting approval of funding (which is linked to the US governments spending review).</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Cambridge</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Mass spectrometry imaging of lung cancer</gtr:description><gtr:id>2A391B39-3C7E-4E3B-B1F5-2711C0FEDD29</gtr:id><gtr:impact>None to date</gtr:impact><gtr:outcomeId>5461e1348eee99.20582474-1</gtr:outcomeId><gtr:partnerContribution>See abive</gtr:partnerContribution><gtr:piContribution>We have initiated a collaboration looking at the development of tumours in an inducible myc mouse model of cancer. Biochemistry will conduct the animal experiments and provide tissue, while we are performing the imaging.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Babraham Institute</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Lipidomics in Cambridge</gtr:description><gtr:id>5B569098-4D66-432D-997D-511506DB7D4C</gtr:id><gtr:impact>This has just begun.</gtr:impact><gtr:outcomeId>M5JSDn9U8y3-1</gtr:outcomeId><gtr:partnerContribution>This partnership will raise the profile of lipidomics in Cambridge and further afield.</gtr:partnerContribution><gtr:piContribution>We are collaborating to provide a comprehensive lipidomic service for academic and pharma in the cambridge area.</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Selcia</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Selcia Industrial CASE award</gtr:description><gtr:id>9C49BFE4-3415-448D-B948-58795D872BB9</gtr:id><gtr:impact>Industrial CASE funding for the student.</gtr:impact><gtr:outcomeId>NsPmiVfogPV-1</gtr:outcomeId><gtr:partnerContribution>We will make use of equipment at Selcia for preparative LC.</gtr:partnerContribution><gtr:piContribution>We are conducting research into the use of yeast as a means to generate labelled lipid standards for the lipidomic community. We will provide expertise in lipid detection and yeast biology while Selcia will provide expertise in preparative LC and stable isotope work.</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Sheffield</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Department of Cardiovascular Science</gtr:department><gtr:description>Understanding the role lipotoxicity plays in hypertension and inflammation</gtr:description><gtr:id>6B928031-F5B0-4EF5-A693-C419CF5F5AE1</gtr:id><gtr:impact>This has led to a programme grant application to the British Heart Foundation.</gtr:impact><gtr:outcomeId>jHJHSFDcAYH-1</gtr:outcomeId><gtr:partnerContribution>They are providing assistance in cell culture techniques - particularly for co-cultures.</gtr:partnerContribution><gtr:piContribution>This is a collaboration with Sheffield University to follow lipid mediators and ROS species in cell culture and animal models of vascular tone and right ventricular hypertrophy.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Medical Research Council (MRC)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>MRC Centre for Obesity and Related Metabolic Diseases</gtr:department><gtr:description>BHF programme grant on BAT</gtr:description><gtr:id>07521273-F95B-4878-BD21-36F4A49DA856</gtr:id><gtr:impact>None to date</gtr:impact><gtr:outcomeId>ZU71q7uMxru-1</gtr:outcomeId><gtr:partnerContribution>The partner is doing the majority of the animal work and molecular biology for this project.</gtr:partnerContribution><gtr:piContribution>Collaboration on a programme grant application to the British Heart Foundation. This has costs for lipidomics to profile eicosanoids and intact lipids in order to understand the role brown adipose tissue may play in treating atherosclerosis.</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Cambridge</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>MRC Epidemiology Unit</gtr:department><gtr:description>Fenland</gtr:description><gtr:id>BFC77864-BF71-45E3-9D03-43D40D56E1EC</gtr:id><gtr:impact>We applied for and were awarded &amp;pound;1.3 million grant to conduct a joint GWAS and metabolomic study in collaboration with MRC epidemiology.</gtr:impact><gtr:outcomeId>WBgXbnobfne-1</gtr:outcomeId><gtr:partnerContribution>MRC Epidemiology have collected the samples and genotyped individuals.</gtr:partnerContribution><gtr:piContribution>We have been collaborating with MRC Epidemiology to profile amino acid metabolism in blood plasma from the Fenland study. We have undertook to expand this analysis to now include intact lipids on 1500 people with genotype information.</gtr:piContribution><gtr:sector>Multiple</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Medical Research Council (MRC)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>MRC Centre for Obesity and Related Metabolic Diseases</gtr:department><gtr:description>Monitoring reactive oxygen species damage in human patients</gtr:description><gtr:id>F4D5361B-A477-4E4B-9194-A77041104F2E</gtr:id><gtr:impact>This collaboration has just begun.</gtr:impact><gtr:outcomeId>QFV6SfoPPgM-2</gtr:outcomeId><gtr:piContribution>We have developed assays to monitor ROS damage in liver and kidney transplant patients and in patients with selenoprotein deficiencies.</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>MRC Harwell</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>MODO consortium</gtr:description><gtr:id>1AF78098-0293-4B60-BB23-6C4A98A18EC3</gtr:id><gtr:impact>We have publications in preparation.</gtr:impact><gtr:outcomeId>op41iG47Acu-1</gtr:outcomeId><gtr:partnerContribution>This has allowed us access to mouse models of great relevance to our work.</gtr:partnerContribution><gtr:piContribution>LPS is part of the MRC Harwell Mouse Models of Diabetes and Obesity (MODO) consortium. This consortium aims to promote the use of mouse mdoels generated at MRC Harwell for use within the wider research community. JLG will attend a informatics training course on the 18th June to enable access to the mouse lines. It is hoped LPS will have access to specific models of type 2 diabetes through the pipeline.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Medical Research Council (MRC)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>MRC Centre for Obesity and Related Metabolic Diseases</gtr:department><gtr:description>Study of lipotoxicity with MRC CORD</gtr:description><gtr:id>9DBC6605-71C2-44E8-AD7A-C128A1755BAC</gtr:id><gtr:impact>This is a multi-discip;inary collaboration spanning analytical chemistry, biochemistry and animal physiology. This collaboration has produced a publication this year and a grant application to the BHF which will be submitted early next year.</gtr:impact><gtr:outcomeId>EVXRaVLCq3D-1</gtr:outcomeId><gtr:partnerContribution>Access to animal models and facilities</gtr:partnerContribution><gtr:piContribution>We have been measuring changes in potentially lipotoxicity species in adipose and liver tissue from animal models of obesity and type II diabetes in conjunction with MRC CORD.</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>EMBL European Bioinformatics Institute (EMBL - EBI)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>MetaboLights EBI project</gtr:description><gtr:id>756ABA39-140E-4E0C-BE69-5A7651552B7E</gtr:id><gtr:impact>This has produced a funded BBSRC grant to take forward the collaboration, a number of publications, and most recently a further application to the EU framework 7 program. In 2013 we have applied for further funding from the BBSRC and MRC to develop these databases.</gtr:impact><gtr:outcomeId>kHUxk4xmSmk-1</gtr:outcomeId><gtr:partnerContribution>This has helped in our databasing and metadata descriptions supporting our collaborative work.</gtr:partnerContribution><gtr:piContribution>We are working with the European Bioinformatics Institute to develop a central repository for metabolomic and lipidomic data for the international community.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Cambridge</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Cambridge Institute of Public Health</gtr:department><gtr:description>EPIC-CVD</gtr:description><gtr:id>5CB20766-05CC-4D8F-94E8-006E605F9FEF</gtr:id><gtr:impact>sample analysis is progress not output yet</gtr:impact><gtr:outcomeId>cQVqgCwL5k4-1</gtr:outcomeId><gtr:partnerContribution>provide samples and joint data analysis</gtr:partnerContribution><gtr:piContribution>The UNIVERSITY, specifically the Cardiovascular Epidemiology Unit in the Department of Public Health and Primary Care, has plasma aliquots from 

CLBRI has agreed to perform fatty acid analysis of the 12,000 stroke (&amp;quot;Sample(s)&amp;quot;) from the EPIC-CVD Study. CLBRI will analyse plasma aliquots by GC-FID for a panel of up to 38 fatty acids in exactly the same manner as has been previously used for Type 2 diabetes cases and controls from the EPIC InterAct study.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Cambridge</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Cardiovascular Epidemiology Unit</gtr:department><gtr:description>EPIC HEART</gtr:description><gtr:id>E04F2308-77E7-4311-BF6E-E902E412E3BE</gtr:id><gtr:impact>not yet</gtr:impact><gtr:outcomeId>DYSDj5UbQLX-1</gtr:outcomeId><gtr:partnerContribution>They will provide the samples and will jointly analyse the data</gtr:partnerContribution><gtr:piContribution>The UNIVERSITY, specifically the Cardiovascular Epidemiology Unit in the Department of Public Health and Primary Care, has plasma aliquots from 

CLBRI has agreed to perform fatty acid analysis of the 12,000 coronary disease cases (&amp;quot;Sample(s)&amp;quot;) from the EPIC-Heart Study. CLBRI will analyse plasma aliquots by GC-FID for a panel of up to 38 fatty acids in exactly the same manner as has been previously used for Type 2 diabetes cases and controls from the EPIC InterAct study.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>GlaxoSmithKline (GSK)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Safety Assessment GSK</gtr:department><gtr:description>GlaxoSmithKline collaboration in lipidomics</gtr:description><gtr:id>2E1DFA0B-3E21-418E-9D69-7C00FD753E42</gtr:id><gtr:impact>This has led to the CASE component being funded for an MRC ITTP studentship in the LPS group.</gtr:impact><gtr:outcomeId>FiNzr9TPejt-1</gtr:outcomeId><gtr:partnerContribution>They will make their laboratories open to the student and have also provided consumables for the student.</gtr:partnerContribution><gtr:piContribution>We have assisted GSK in a number of projects centred around lipidomics and metabolomics, both in diabetes and toxicology research. The most recent area has been in understanding phospholipidosis, a problem of a number of widely administered drugs, and its relevance to fatty organ disease (particularly the liver, but also fat infiltration into lungs and brain tissue) and lysosomal storage disorders.</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Pennsylvania</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:department>Institute for Translational Medicine and Therapeutics (ITMAT)</gtr:department><gtr:description>PPAR-alpha and inflammation in humans</gtr:description><gtr:id>F0B197A9-5546-4BE9-8454-218D79307EE2</gtr:id><gtr:impact>None to date</gtr:impact><gtr:outcomeId>W4jvRGgwrgW-1</gtr:outcomeId><gtr:partnerContribution>They are conducting the clinical trial which will provide the samples to be analyzed at HNR.</gtr:partnerContribution><gtr:piContribution>LPS is collaborating with the University of Pennsylvania to look at human blood plasma from a study looking at the role PPAR-alpha plays in preventing inflammation in adipose tissue. This is an NIH-sponsored clinical research study into the Fenofibrate and Omega-3 Fatty Acid Modulation of Endotoxemia inflammation of adipose tissue (a model for inflammation associated insulin resistance). This work nicely compliments the programme work for LPS and may lead to a proposal to the NIH if the experiments are successful. Given this, LPS would like to 'absorb' the costs into the Burning fat project of LPS in the expectation that this work adds value and may pave the way for further funds in the future. Jonathan Powell suggested that the LPS group also consider using their samples for hepcidin analysis (all 3 hepcidin variants) as an off-subject but &amp;quot;added value&amp;quot; idea. HNR would not be involved. The proposal was just for information.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>AstraZeneca</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Cambridge Metabolism Network</gtr:description><gtr:id>AC500053-A57C-4B7F-A238-E843E8F55EFE</gtr:id><gtr:impact>Got a CASE studentship in a multi-disciplinary research area.</gtr:impact><gtr:outcomeId>56d81ce3a1b8a6.24246837-2</gtr:outcomeId><gtr:partnerContribution>To my group they have provided a PhD studentship.</gtr:partnerContribution><gtr:piContribution>I am a member of the organising committee for the Cambridge Metabolomics Network. This has included two meetings on metabolism. The events have been sponsored by AZ, MedImmune and Novartis and contact with AZ led to a CASE pHD studentship.</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2015-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Institute for Cancer Research (Istituto di Candiolo IRCCS)</gtr:collaboratingOrganisation><gtr:country>Italy, Italian Republic</gtr:country><gtr:description>Collaboration with Department of Epidemiology and Prevention, IRCCS Istituto Neurologico Mediterraneo Neuromed, Italy re Lipidomics &amp;amp; Poliphemus</gtr:description><gtr:id>6E57B665-8887-4E0C-8F14-F8CB29F03AF9</gtr:id><gtr:impact>TBC</gtr:impact><gtr:outcomeId>546332dda92fa7.45146438-1</gtr:outcomeId><gtr:partnerContribution>Licia Iacoviello, MD, PhD, Head, Laboratory of Molecular and Nutritional Epidemiology</gtr:partnerContribution><gtr:piContribution>Michele Vacca and Jules Griffin approached Michele's former group to establish a collaboration for studying serum metabolomics in healthy subjects and patients with Metabolic Syndrome before and after nutritional interventions.</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>King's College Hospital Charity</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Collaboration with Academic Rheumatology, King's College London</gtr:description><gtr:id>881626CE-79DC-462A-A0E4-C8D6382C2834</gtr:id><gtr:impact>Grant application by King's College</gtr:impact><gtr:outcomeId>5461e04b602036.59070079-1</gtr:outcomeId><gtr:partnerContribution>See above</gtr:partnerContribution><gtr:piContribution>I agreed to collaborate on a grant examining the role of the mevalonate pathway in the immune system. While we will receive costs for the analyses performed this is also of interest as the immune system induced inflammation is a major cause of insulin resistance.</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Unilever</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Unilever funding for a PhD studentship</gtr:description><gtr:id>61CF532E-90BA-4656-9E73-36DA6FC23944</gtr:id><gtr:impact>CASE funding for a PhD student.</gtr:impact><gtr:outcomeId>ks42ePHsyHH-1</gtr:outcomeId><gtr:partnerContribution>They will make their labs open to the student to perform experiments there.</gtr:partnerContribution><gtr:piContribution>Unilever have an interest in how diet influences diseases of dyslipidaemia and in particular the role epigenetics plays in this process. They have CASE funded a PhD student to work in this area.</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University College London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Xtreme everest</gtr:description><gtr:id>6E2D0C53-7FD9-4458-BC69-A4D352BF4C57</gtr:id><gtr:impact>None to date</gtr:impact><gtr:outcomeId>jgXfC37gB9N-1</gtr:outcomeId><gtr:partnerContribution>Organising the Xtreme Everest expedition</gtr:partnerContribution><gtr:piContribution>Members of LPS will analyse samples from the Xtreme Everest 2 expedition. This expedition will take volunteers from Kathmandu to Everest basecamp to examine adaptation to low oxygen levels. This is the second expedition, with the first attracting much media interest and a Horizon program. LPS are particularly interested in the concept of induction of PPAR-alpha in human skeletal muscle at high altitude as this appears counterintuitive since this would stimulate fatty acid metabolism at high altitude which is more oxygen demanding in terms of the ATP produced compared with increased glycolysis and metabolism of glucose. Two members of LPS will also join the expedition for the first three weeks and spend three days at Everest basecamp.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Junior school science talk</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>4E314E29-3E8A-44C8-8196-EBCB3E136BB7</gtr:id><gtr:impact>We have given science talks on temperature and food to approximately fifty eight year olds.

We are taking part in a larger science fair to be organised this coming year.</gtr:impact><gtr:outcomeId>LS6dCqnJi1J</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Workshop Facilitator</gtr:presentationType><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2011,2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>BBC filming as part of a news report on fat metabolism</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>4C5AD941-98D2-456C-A78F-5C37B6BB9319</gtr:id><gtr:impact>With MRC Epidemiology we took part in a documentary by the BBC on fat intake. This has led to a number of other media contacts since then.</gtr:impact><gtr:outcomeId>56d8184f23c2a7.38352670</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Science career advice to prospective undergraduates</gtr:description><gtr:form>Participation in an open day or visit at my research institution</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>B37E7FB7-FA87-4849-8608-E5F81E4F2547</gtr:id><gtr:impact>This was a talk as part of an open day In cambridge to encourage students to study Natural sciences at Cambridge.

I received a number of requests for further information from students.</gtr:impact><gtr:outcomeId>jKW8WdpgPMo</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2011,2012,2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>How the fat flies - Science Week</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>69879B0E-93D3-4C6E-B52D-F203C880E5B6</gtr:id><gtr:impact>The University of Cambridge Science Festival took place on Saturday 14th and Sunday 15th March. My group had a stand at the Corn Exchange. The stand was split into two, with one half focusing on nutrition and the other on mass spectrometry.</gtr:impact><gtr:outcomeId>56d819d070a8a9.38969733</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Daily Mail piece</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>D9850BEB-C015-4BA4-9068-32492355D919</gtr:id><gtr:impact>JG was approached by the Daily Mail via MRC Head Office concerning Circadian rythmns in fat. This work was published in the newspaper.

We have since been contacted to help with an Horizon programme and a piece appeared in the Wallstreet journal too.</gtr:impact><gtr:outcomeId>USwMZBjJzzu</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Paper Presentation</gtr:presentationType><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Graduate School of Life Sciences, University of Cambridge</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>4A09BFF2-5AE9-430B-85F0-FD17A07DE04A</gtr:id><gtr:impact>Introduction to statistics for graduates in the life sciences to help with their research

Has given the students added confidence to use these tools</gtr:impact><gtr:outcomeId>5461e66261fd31.39947326</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Postgraduate students</gtr:primaryAudience><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>CoOrganiser of a Workshop on Metabolomics in Sardinia, Italy</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>48332323-D73B-4397-A6C5-DDBA07C1213F</gtr:id><gtr:impact>We arranged a week long work shop on Sardinia and funded students to attend through a number of EU initiatives. The aim was to increase their experience and help them in their projects. We received very favourable feedback.

TBC</gtr:impact><gtr:outcomeId>546379770cb518.47491136</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:presentationType>keynote/invited speaker</gtr:presentationType><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Small Molecule Inter-organ Crosstalk and the Browning of White Adipose Tissue talk, School of Biomedical Sciences, University of Leeds (Lee Roberts)</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>05CDA6B6-13C8-4DEB-8307-B39EC56655F7</gtr:id><gtr:impact>TBC</gtr:impact><gtr:outcomeId>546375f4a6efd2.63246872</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Other academic audiences (collaborators, peers etc.)</gtr:primaryAudience><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Metabolomics workshop for industry</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>D500B894-EE6D-4141-A22F-330FA7060100</gtr:id><gtr:impact>Members of LPS co-organised a European Bioinformatics Instuitute Industrail Collaboration Workshop on Metabolomics and Lipidomics. Albert Koulman and Michael Eiden also attended this meeting.

This raised the profile of our research with industry.</gtr:impact><gtr:outcomeId>cvCV7G9MLdP</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Workshop Facilitator</gtr:presentationType><gtr:primaryAudience>Other academic audiences (collaborators, peers etc.)</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Contact with the BBC about  a scientific program on diet and food</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>C84B443B-C2F4-4FA6-AA6D-57985A53408E</gtr:id><gtr:impact>CW contacted by Milla Harrison from the BBC doing another Horizon programme - The Biology and Environmental factors behind Obesity. Wanted some advice on genes and genotyping.</gtr:impact><gtr:outcomeId>56dac3325f4682.40934805</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Warburg and the War on cancer: Metabolism and treating cancer</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>F4AC6C7F-485C-4684-930F-4FAAECE8EEDC</gtr:id><gtr:impact>Gave a talk at the Experimental Biology meeting detailing how metabolomics can be used to treat cancer in the future.</gtr:impact><gtr:outcomeId>56d828991084a4.77712654</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Workshop at the university of cambridge to train students in physiology</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>9E7F3631-C96C-41E0-9674-B74995D051CF</gtr:id><gtr:impact>Members of LPS are contributing to a four day workshop sponsored by the European Atheroscelrosis Society on Phenotyping mouse models of the Metabolic Syndrome.

None to date.</gtr:impact><gtr:outcomeId>nB8yjUjb48t</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Workshop Facilitator</gtr:presentationType><gtr:primaryAudience>Postgraduate students</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Introduction to Systems Biology Course delivered to school children at St. John's College (led by James Smith)</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>A910E6AC-0E2D-4396-8500-A6E36988FB11</gtr:id><gtr:impact>TBC</gtr:impact><gtr:outcomeId>54636a7220d3e9.00130727</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Workshop at the Wellcome Trust roganised by the WT/Diabetes Juvenille Diabetes Foundation on autoimmune diseases</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>2DB71CF8-75EB-4D9B-B597-BFEDCE2244DB</gtr:id><gtr:impact>Talk sparked questions and discussion after

I have initiated one collaboration and had other talk invitations on the back of my presentation.</gtr:impact><gtr:outcomeId>5461f39d53e229.36539045</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Other academic audiences (collaborators, peers etc.)</gtr:primaryAudience><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Metabolomics Workshop at the 20th International Symposium on Microsomes and drug oxidations, stuttgart, germany</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>8C238CB9-9CE3-4C20-A737-459C8F46ED80</gtr:id><gtr:impact>academics said they would incorporate metabolomics into their future experiments

See above</gtr:impact><gtr:outcomeId>5461e5a32d2e87.69919748</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Other academic audiences (collaborators, peers etc.)</gtr:primaryAudience><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Workshop at Metabolomics Society 2013</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>283CF6B8-053C-409F-BB40-3DA679A93CDE</gtr:id><gtr:impact>~100 active researchers attended the workshop.

None to date</gtr:impact><gtr:outcomeId>kJp395Rma2r</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:presentationType>Workshop Facilitator</gtr:presentationType><gtr:primaryAudience>Other academic audiences (collaborators, peers etc.)</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Science Week cambridge 2016</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>F7A25163-3369-4D46-B598-17071A8285F0</gtr:id><gtr:impact>: volunteering on 13th March 2016 Cambridge science festival HNR stand: Blood, Fat &amp;amp; the Future</gtr:impact><gtr:outcomeId>58be907dd3b644.52931237</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Hosted a visit from Singaporean students</gtr:description><gtr:form>Participation in an open day or visit at my research institution</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>8A649F41-9EA4-42C5-A338-0BF83BE219D6</gtr:id><gtr:impact>We hosted a visit from 6th form Singaporean students interested in applying to Cambridge as undergraduates in science related areas.

They gave me a box of chocolates!</gtr:impact><gtr:outcomeId>pgJCs9prsnn</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Presentation at the European Association for the study of Diabetes Conference in Vienna, September 2014</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>BEDA2B3A-E624-47D8-B360-C1B29FE9B848</gtr:id><gtr:impact>TBC</gtr:impact><gtr:outcomeId>5463784b043942.53330151</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Debating matters - regional final judge</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>3006BC48-42D7-415D-B885-99080A5897D3</gtr:id><gtr:impact>We encouraged students to both debate and think about applying to the University of Cambridge

see above</gtr:impact><gtr:outcomeId>5461e4b6057018.14149414</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Poster presentation at Experimental Biology 2015</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>093C9B7F-21A1-486A-BF78-E77BD99F1482</gtr:id><gtr:impact>One of the PhD students attended Experimental Biology and presented a poster entitled &amp;quot;Effects of green tea and coffee polyphenols on cardiometabolic function in women with Polycystic Ovary Syndrome.&amp;quot; Experimental Biology Boston, USA, 28 March-1 April 2015.</gtr:impact><gtr:outcomeId>56d8223dc1f830.96850998</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Cambridge Science Week 2017</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>AFEC8016-CB8F-4890-A105-E4794702EDA1</gtr:id><gtr:impact>took part in Cambridge Science week and put on a display on personalised medicine and health using advanced biochemical techniques.</gtr:impact><gtr:outcomeId>58c6c9ae213365.21891236</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2017</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Work experience for two school boys</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>66B8DCF3-5379-4CDF-990F-F7708459CAD2</gtr:id><gtr:impact>Work experience for two school boys: two school boys spent a week in my lab following members around to get some experience of what its like being a scientist.</gtr:impact><gtr:outcomeId>58be9ca3c4fbb4.99465167</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>French Embassy Seed meeting</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>3FB3FFCE-1B7F-4769-8B08-AEF26D6777E6</gtr:id><gtr:impact>JLG, LR, AA and ZA were invited to the French Embassy to discuss collaborations with colleagues from INRA on metabolomics. This was following a successful application to the French government to fund the meeting by JLG and his counterparts in France.</gtr:impact><gtr:outcomeId>56d981973f3ce1.49481057</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Discussion with Trust me I'm a doctor</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>DDFEA40B-3462-44BC-AF93-CA810470260C</gtr:id><gtr:impact>I advised on a program on energy balance and dieting pills.

Still waiting for the program to air!</gtr:impact><gtr:outcomeId>5461e6fb7a9a77.00213230</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Media Coverage - Everest challenge</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>BEA5AB33-FA3E-4B83-AE2D-B586AE236C36</gtr:id><gtr:impact>1 regional radio interivew and article in regional newspaper for taking part in Extreme Everest challenge.

Building up links with media, disseminating research to media and public, and raising profile of unit's work.</gtr:impact><gtr:outcomeId>hzfmA6tnoUL</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>BD2K NIH workshop</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>3340EAB6-8121-42D1-9A84-E245E9C2FEB7</gtr:id><gtr:impact>JG attended a workshop for the NIH Big Data to Knowledge Initiative (BD2K). This is a workshop on community-based standards efforts related to scientific data. The NIH will sponsor his attendance at this workshop, which was held September 25 - 26 in Rockville, Maryland.

Advised the NIH on how best to roll out initiatives in this research area</gtr:impact><gtr:outcomeId>boS7iXjzSeh</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Policymakers/parliamentarians</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Workshop on New MS-tools, Wageningen, Natherlands</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>F4FEE913-BD68-4A4E-AB2A-50D7D9A8B6CE</gtr:id><gtr:impact>Talk sparked questions and discussions afterwards

We have continued discussing new technologies and how we might incorporate them into our workflows</gtr:impact><gtr:outcomeId>5461f1c4d79b67.11707743</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Other academic audiences (collaborators, peers etc.)</gtr:primaryAudience><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Sugar, Fat and the Daily Mail Headlines</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>EF245EA2-6786-4946-AD7A-83211F9BB475</gtr:id><gtr:impact>JLG spoke at the 'Skeptics in the Pub' event on 26th May. The video is on YouTube should anyone want to view it!</gtr:impact><gtr:outcomeId>56d8576b8b49d5.72654736</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>LPS at Science week</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>E7F6FD4E-E0E8-4BD0-8E99-8DF09FFD8FF7</gtr:id><gtr:impact>The Cambridge Science festival attracts 1000s of members of the public to the centre of cambridge to see various displays of science in action. We took part in the HNR's contribution, explaining mass spectrometry and its role in obesity and diabetes research.

None to date.</gtr:impact><gtr:outcomeId>s2Per7Z9PH2</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:presentationType>Workshop Facilitator</gtr:presentationType><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Press release for circadian rhythms</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>503CFF27-73FC-4964-B20A-41C3F5E43986</gtr:id><gtr:impact>We produced a press release on work published in Nature Medicine on circadian rhythms in adipose tissue.

This led to contact with a journalist producing an article on obesity and its link with sleep.</gtr:impact><gtr:outcomeId>KNSRtcrePZk</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Paper Presentation</gtr:presentationType><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Head Start science scheme for sixth form students</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>576141F2-4C1A-44E2-AE1F-69324B333AF2</gtr:id><gtr:impact>We hosted approximately thirty sixth form students for a seminar on metabolism followed by an introduction to a typical undergraduate practical class. The practical class was augmented by a practical demonstration of metabolomics where the students analyzed their own urine by high resolution 1H NMR spectroscopy and computer assisted pattern recognition to determine who was male and who was female!

We have already had a request to continue this workshop next year. A number of the students have since applied to Oxbridge despite being from schools that typically do not send students to the top universities.</gtr:impact><gtr:outcomeId>hnxvYzkLESf</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>2nd Metabolomics Sardinian Scientific School</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>A02BD3F7-F83F-4C32-B660-ED3BC6C2D6B0</gtr:id><gtr:impact>2nd Metabolomics Sardinian Scientific School was aimed at post-grad students new to the field of metabolomics. We gave seminars and workshops in various tools and techniques in metabolomics.</gtr:impact><gtr:outcomeId>58be91ffd0e376.17281807</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Postgraduate students</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Talk on metabolomics at Bedford School</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>D410B844-594E-496F-A9F3-267F599D71B4</gtr:id><gtr:impact>Gave a talk on metabolomics and systems biology to the biology club at Bedford school.</gtr:impact><gtr:outcomeId>56d829169367c8.11537766</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>18000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC CASE studentship</gtr:description><gtr:end>2014-09-02</gtr:end><gtr:fundingOrg>Unilever</gtr:fundingOrg><gtr:id>72AF4072-E884-4720-A5BB-E4721BDC0E5E</gtr:id><gtr:outcomeId>meu6xJ9Rhit1</gtr:outcomeId><gtr:sector>Private</gtr:sector><gtr:start>2011-09-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>864000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>BBSRC responsive mode grant</gtr:description><gtr:end>2017-06-02</gtr:end><gtr:fundingOrg>Biotechnology and Biological Sciences Research Council (BBSRC)</gtr:fundingOrg><gtr:id>CD6DE0D5-AA90-4392-B653-7F4F3E012F4A</gtr:id><gtr:outcomeId>5461fdbcac0d30.88336245</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2014-07-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>65000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>BBSRC Industrial CASE award</gtr:description><gtr:end>2014-09-02</gtr:end><gtr:fundingOrg>Biotechnology and Biological Sciences Research Council (BBSRC)</gtr:fundingOrg><gtr:id>5CEAF646-4733-4FCA-B6AF-C7CD0DC6B8C6</gtr:id><gtr:outcomeId>cVjeAjPSBmt0</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2011-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>420179</gtr:amountPounds><gtr:country>United States of America</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Optimized Metabolite Extraction, Separation, and Identification for Metabolomics</gtr:description><gtr:end>2017-04-02</gtr:end><gtr:fundingOrg>National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)</gtr:fundingOrg><gtr:id>95973E9B-B3CC-4B1C-AE84-616D56E8B7BD</gtr:id><gtr:outcomeId>cp3sC3otRpJ</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2013-05-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>3000</gtr:amountPounds><gtr:country>United States of America</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Amegen Summer studentship - Xavier Fernandez</gtr:description><gtr:end>2015-08-02</gtr:end><gtr:fundingOrg>Amgen Inc</gtr:fundingOrg><gtr:id>FCE808F9-CA4E-4E8F-8B83-EE12E08467D0</gtr:id><gtr:outcomeId>56d97ea22699a6.29604304</gtr:outcomeId><gtr:sector>Private</gtr:sector><gtr:start>2015-06-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>110442</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>British Heart Foundation PhD Studentship</gtr:description><gtr:end>2015-09-02</gtr:end><gtr:fundingOrg>British Heart Foundation (BHF)</gtr:fundingOrg><gtr:id>B5E17BCA-7215-45C1-B04B-4D412E858CBC</gtr:id><gtr:outcomeId>SHRgqsCVWPX</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2012-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>65000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Wellcome Trust and GSK studentship in translational medicine</gtr:description><gtr:end>2016-09-02</gtr:end><gtr:fundingOrg>Wellcome Trust</gtr:fundingOrg><gtr:id>DD1AED9F-7F50-4F49-8BBE-CA0EBC59A74A</gtr:id><gtr:outcomeId>ir6iEYAjpAK</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2013-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>60000</gtr:amountPounds><gtr:country>Global</gtr:country><gtr:currCode>EUR</gtr:currCode><gtr:currCountryCode>Austria</gtr:currCountryCode><gtr:currLang>de_AT</gtr:currLang><gtr:description>Marie Curie Mobility Fellowship</gtr:description><gtr:end>2016-09-02</gtr:end><gtr:fundingOrg>Marie Sklodowska-Curie Actions</gtr:fundingOrg><gtr:fundingRef>Not known</gtr:fundingRef><gtr:id>57C579CD-AAA9-478E-8636-5CC996ADF14C</gtr:id><gtr:outcomeId>56d97ae9d66f83.13080787</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2015-09-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>18000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>BBSRC Industrial CASE award</gtr:description><gtr:end>2014-09-02</gtr:end><gtr:fundingOrg>Selcia</gtr:fundingOrg><gtr:id>2F9EA204-CEFA-4148-8720-0DC61F419E88</gtr:id><gtr:outcomeId>cVjeAjPSBmt1</gtr:outcomeId><gtr:sector>Private</gtr:sector><gtr:start>2011-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>245000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Metabolights: Creating the missing metabolomics community database resource.</gtr:description><gtr:end>2013-09-02</gtr:end><gtr:fundingOrg>Biotechnology and Biological Sciences Research Council (BBSRC)</gtr:fundingOrg><gtr:id>888C8394-147E-49F2-8046-9AD7B521DE37</gtr:id><gtr:outcomeId>Ugr1E3MZ5ni0</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2010-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>65000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC CASE studentship</gtr:description><gtr:end>2014-09-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>108F2E1F-FAEB-405C-A299-EB983E95FE37</gtr:id><gtr:outcomeId>meu6xJ9Rhit0</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>100000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>MedImmune Cambridge</gtr:department><gtr:description>Medimmune industrial studentship</gtr:description><gtr:end>2019-09-02</gtr:end><gtr:fundingOrg>MedImmune</gtr:fundingOrg><gtr:id>13FB722B-6A43-4D26-BF81-BB10148471E1</gtr:id><gtr:outcomeId>58beba775feb94.63297316</gtr:outcomeId><gtr:sector>Private</gtr:sector><gtr:start>2016-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>1300000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>High-throughput &amp;quot;omic&amp;quot; science and imaging call</gtr:description><gtr:end>2014-07-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>B58C8C05-1002-40A1-BD43-E082874BE2FE</gtr:id><gtr:outcomeId>QvtHpyVAvEp</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2013-07-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>25000</gtr:amountPounds><gtr:country>Global</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>Philips</gtr:department><gtr:description>EPSRC Industrial Studentship</gtr:description><gtr:end>2016-09-02</gtr:end><gtr:fundingOrg>Koninklijke Philips Electronics N.V.</gtr:fundingOrg><gtr:id>BA40CE0E-84CE-48A2-808A-EA406D3643DB</gtr:id><gtr:outcomeId>brVkKtUdMyD1</gtr:outcomeId><gtr:sector>Private</gtr:sector><gtr:start>2011-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>360000</gtr:amountPounds><gtr:country>European Union (EU)</gtr:country><gtr:currCode>EUR</gtr:currCode><gtr:currCountryCode>Austria</gtr:currCountryCode><gtr:currLang>de_AT</gtr:currLang><gtr:department>Seventh Framework Programme (FP7)</gtr:department><gtr:description>EU FP7 EPIC CVD</gtr:description><gtr:end>2014-09-02</gtr:end><gtr:fundingOrg>European Commission</gtr:fundingOrg><gtr:id>267D2FA5-C7B3-41A8-AB1B-53F50CADC36B</gtr:id><gtr:outcomeId>S4QtNf3dHE5</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2013-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>124000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Technology Development Grant, MetaboFlow - the development of standardised workflows for processing metabolomics data to aid reproducible data sharing and big data initiatives</gtr:description><gtr:end>2019-11-02</gtr:end><gtr:fundingOrg>Wellcome Trust</gtr:fundingOrg><gtr:fundingRef>202952/B/16/Z</gtr:fundingRef><gtr:id>E579BA0D-62C5-4E43-84A5-88EDA6261EBF</gtr:id><gtr:outcomeId>58c6c5f430db06.11331108</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2016-12-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>225000</gtr:amountPounds><gtr:country>European Union (EU)</gtr:country><gtr:currCode>EUR</gtr:currCode><gtr:currCountryCode>Austria</gtr:currCountryCode><gtr:currLang>de_AT</gtr:currLang><gtr:description>ERC Senior Investigator Awaard - EPIC Heart</gtr:description><gtr:end>2017-08-02</gtr:end><gtr:fundingOrg>European Research Council (ERC)</gtr:fundingOrg><gtr:id>82CAA039-FF52-4F36-AE5F-3422F391BDF5</gtr:id><gtr:outcomeId>psaq8D1GSdi</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2013-09-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>550000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>DRINC - Validation of Biomarkers of efficacy for fetal nutrition</gtr:description><gtr:end>2018-09-02</gtr:end><gtr:fundingOrg>Biotechnology and Biological Sciences Research Council (BBSRC)</gtr:fundingOrg><gtr:fundingRef>BB/M027252/1</gtr:fundingRef><gtr:id>73FA747A-AF98-4BA8-95DA-75ABDB72383D</gtr:id><gtr:outcomeId>56d97c56deccf1.67973808</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2015-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>76184</gtr:amountPounds><gtr:country>European Union (EU)</gtr:country><gtr:currCode>EUR</gtr:currCode><gtr:currCountryCode>Austria</gtr:currCountryCode><gtr:currLang>de_AT</gtr:currLang><gtr:department>Seventh Framework Programme (FP7)</gtr:department><gtr:description>COSMOS</gtr:description><gtr:end>2015-10-02</gtr:end><gtr:fundingOrg>European Commission</gtr:fundingOrg><gtr:id>C9354A83-5A33-41ED-9993-67F0B4FBCEE0</gtr:id><gtr:outcomeId>TAmnJRnqA3G</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2012-11-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>485000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>BBSRC project grant - Burning fat, understanding the role of PPAR delta in adipose tissue</gtr:description><gtr:end>2013-11-02</gtr:end><gtr:fundingOrg>Biotechnology and Biological Sciences Research Council (BBSRC)</gtr:fundingOrg><gtr:id>F25A488B-EEF6-4FCC-99B3-9F41C3F73B92</gtr:id><gtr:outcomeId>RbGt43AyXwT0</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2010-12-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>11679000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Medical Research Council Bioinformatics Structure</gtr:description><gtr:end>2017-06-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>78923847-D23A-4C9A-8CD5-E7D9A5296977</gtr:id><gtr:outcomeId>5461fe4c011616.61318574</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2014-07-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>22000</gtr:amountPounds><gtr:country>Global</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>GlaxoSmithKline conversion of a studentship to a CASE award</gtr:description><gtr:end>2013-09-02</gtr:end><gtr:fundingOrg>GlaxoSmithKline (GSK)</gtr:fundingOrg><gtr:id>E8D4A427-A6C4-4DED-B2B9-40289A9F373F</gtr:id><gtr:outcomeId>MFm6VRo1md80</gtr:outcomeId><gtr:sector>Private</gtr:sector><gtr:start>2011-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>33000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC Centenary Award NB</gtr:description><gtr:end>2013-09-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>CC631B6E-667F-451F-A8A2-049A4978CF60</gtr:id><gtr:outcomeId>FpdenGPNUBR</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>40000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Astra Zeneca CASE studentship</gtr:description><gtr:end>2019-09-02</gtr:end><gtr:fundingOrg>AstraZeneca</gtr:fundingOrg><gtr:id>5E1E4628-1D9E-45ED-A0AB-BA19CD847311</gtr:id><gtr:outcomeId>58beaca44e25d0.84768316</gtr:outcomeId><gtr:sector>Private</gtr:sector><gtr:start>2016-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>65000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>EPSRC Industrial Studentship</gtr:description><gtr:end>2016-09-02</gtr:end><gtr:fundingOrg>Engineering and Physical Sciences Research Council (EPSRC)</gtr:fundingOrg><gtr:id>14974428-065B-4047-BCA2-BCBC14F32CEB</gtr:id><gtr:outcomeId>brVkKtUdMyD0</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>417000</gtr:amountPounds><gtr:country>Global</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>GSK-Astra Zeneca partnership awards</gtr:description><gtr:end>2020-03-02</gtr:end><gtr:fundingOrg>GlaxoSmithKline (GSK)</gtr:fundingOrg><gtr:id>5BE7945A-6DE3-4F5D-81CD-30F057B5584A</gtr:id><gtr:outcomeId>58c6cb9b7e9075.35425051</gtr:outcomeId><gtr:sector>Private</gtr:sector><gtr:start>2017-04-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>30000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>BHF Intermediate fellowship for KT</gtr:description><gtr:end>2019-09-02</gtr:end><gtr:fundingOrg>British Heart Foundation (BHF)</gtr:fundingOrg><gtr:id>1439712E-395F-4D3A-B719-5BFEB40865DA</gtr:id><gtr:outcomeId>58c6c6b86c0f76.83569107</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2016-10-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>SACN advisory committee on dietary fats</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>A2E2912A-AA65-47EA-9DD6-C3961434BECE</gtr:id><gtr:outcomeId>56dac24a0bd645.44993539</gtr:outcomeId><gtr:type>Participation in a advisory committee</gtr:type></gtr:policyInfluenceOutput></gtr:policyInfluenceOutputs><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>HNR's bioinformatics team has developed a centralised data processing platform facilitating the reproducible analysis of large-scale studies carried out on high-resolution mass-spectrometry instruments.</gtr:description><gtr:id>06457BC3-3F7C-4B25-A2D4-4BA7988F83E9</gtr:id><gtr:impact>Currently, a wide range of different instruments types are used in the lipidomics community with instrument manufacturers specifying proprietary file formats and supplying their own analysis software. Most of these commercially available software packages are designed as closed source systems, so details on how algorithms are implemented and how parameters are specified remains unclear to the end-user. In addition, commercial software packages are often not designed in a scalable way, i.e. they are not able to handle extremely large sample cohorts. These problems often result in a lack of reproducibility and transparency which makes it very difficult to compare results across different labs and thus can be regarded as one of the biggest challenges facing the whole community. To overcome this problem HNR's bioinformatics team has developed a data processing platform, which relies on open standards and open software. The system is workflow-based and each step of data processing is transparent to the end-user. All settings used can be predefined, facilitating the reproducible analysis of any given data set at any given point in time. In addition, parameter files describing the settings for complex operations (for example from peak picking in spectral raw data to statistical analysis) can be easily run by non-experts ensuring optimal results can be achieved any time. Furthermore, parameters sets and workflows can easily be shared amongst researchers working in different labs. Within LPS, Caldera serves as the central framework for data processing, and is successfully used in context of a large variety of studies conducted on different instrument types.</gtr:impact><gtr:outcomeId>EKGkro8zVPx</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>Caldera</gtr:title><gtr:type>Improvements to research infrastructure</gtr:type></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>For the annotation of spectral peaks HNR's bioinformatics team has developed an in-house compound database containing several thousand lipid species.</gtr:description><gtr:id>354DCB7A-95BD-487A-BDE8-04E6FC98D8F3</gtr:id><gtr:impact>Lipidomics data, especially when generated using high-resolution mass spectrometry instruments, are of a complex nature and can easily contain thousands of individual spectral features. The annotation of these features (so called peaks) is crucial for the interpretation of data in the biological context. CompDB is specifically tailored to work with complex input data and can handle large queries in in a fast and automated way, which cannot be achieved using openly available web-based compound databases. Furthermore, it also provides more flexibility for the user - it (for example) allows the automated search for potential putative adduct formations that are observed frequently in &amp;quot;soft ionisation&amp;quot; techniques and are often difficult and very time-consuming to detect in a manual database searches. In addition, CompDB keeps track of successfully annotated peaks as well as of so called &amp;quot;Unknowns&amp;quot; making it a valuable source of information for future experiments or for the characterisation of specific sample types. Within LPS, CompDB serves as a central starting point for the non-ambiguous identification of compounds and thus is crucial for all on-going lipidomics research at HNR. The database design is scalable, ensuring that it is fit for future demands.</gtr:impact><gtr:outcomeId>ZpmHv9Cg3oA</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>CompDB</gtr:title><gtr:type>Biological samples</gtr:type></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>4640669A-30B9-496E-8746-F41176A453A1</gtr:id><gtr:title>Integration of metabolomics, lipidomics and clinical data using a machine learning method.</gtr:title><gtr:parentPublicationTitle>BMC bioinformatics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5a4c5bb2295df1ba4ff1ccbe4d58a364"><gtr:id>5a4c5bb2295df1ba4ff1ccbe4d58a364</gtr:id><gtr:otherNames>Acharjee A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1471-2105</gtr:issn><gtr:outcomeId>58bd343d1d3e49.97725497</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D2EB1D3A-E8CE-44C2-845D-45BF6EE560E6</gtr:id><gtr:title>Antioxidants and HNE in redox homeostasis.</gtr:title><gtr:parentPublicationTitle>Free radical biology &amp; medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5642aa2b1d5777a7f41482b60783ed82"><gtr:id>5642aa2b1d5777a7f41482b60783ed82</gtr:id><gtr:otherNames>Luczaj W</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0891-5849</gtr:issn><gtr:outcomeId>585d6b01b0ad55.35757089</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F0EFE2E2-D24F-48CB-AFE9-D953113CDC8C</gtr:id><gtr:title>Altered colonic mucosal Polyunsaturated Fatty Acid (PUFA) derived lipid mediators in ulcerative colitis: new insight into relationship with disease activity and pathophysiology.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7a65143bcd0487f501fb7eca36c8622f"><gtr:id>7a65143bcd0487f501fb7eca36c8622f</gtr:id><gtr:otherNames>Masoodi M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>5461fa8973cb27.20279622</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E30E37DF-5448-4699-813F-54C469BA9BC0</gtr:id><gtr:title>A metabolomic study of adipose tissue in mice with a disruption of the circadian system.</gtr:title><gtr:parentPublicationTitle>Molecular bioSystems</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/91d7098c12f9ac872ccb48d93bd0b20a"><gtr:id>91d7098c12f9ac872ccb48d93bd0b20a</gtr:id><gtr:otherNames>Castro C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1742-2051</gtr:issn><gtr:outcomeId>569d100fea920</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>47A9584F-37C3-4CFF-BFF1-BC5902B8C2DA</gtr:id><gtr:title>Impact of Azithromycin on the Quorum Sensing-Controlled Proteome of Pseudomonas aeruginosa.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8e95bcda54491054cd161a2e5400d405"><gtr:id>8e95bcda54491054cd161a2e5400d405</gtr:id><gtr:otherNames>Swatton JE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>56bb5ecb356205.15721361</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A24136AA-34B2-4275-96A2-0B14D837E8A0</gtr:id><gtr:title>Applications of metabolomics for understanding the action of peroxisome proliferator-activated receptors (PPARs) in diabetes, obesity and cancer.</gtr:title><gtr:parentPublicationTitle>Genome medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/605afa4d43c7798be6ab908c49549eb0"><gtr:id>605afa4d43c7798be6ab908c49549eb0</gtr:id><gtr:otherNames>Ament Z</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1756-994X</gtr:issn><gtr:outcomeId>pm_13207_27_22546357</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AD01FF52-5D76-4B74-A2CD-5BE975EBB555</gtr:id><gtr:title>A metabolomics investigation of non-genotoxic carcinogenicity in the rat.</gtr:title><gtr:parentPublicationTitle>Journal of proteome research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/605afa4d43c7798be6ab908c49549eb0"><gtr:id>605afa4d43c7798be6ab908c49549eb0</gtr:id><gtr:otherNames>Ament Z</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1535-3893</gtr:issn><gtr:outcomeId>doi_55f94d94d0a45225</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C3F3DA9D-1FD1-46CD-951C-CEDA72554595</gtr:id><gtr:title>NMR-based metabolomics in human disease diagnosis: applications, limitations, and recommendations</gtr:title><gtr:parentPublicationTitle>Metabolomics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5d0295caecf436c71b10a8e1cbd75b87"><gtr:id>5d0295caecf436c71b10a8e1cbd75b87</gtr:id><gtr:otherNames>Emwas A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:outcomeId>doi_13207_013_0524_y</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2E9F8F07-66A0-4976-ACDA-4AC3D903FDA0</gtr:id><gtr:title>Blood triacylglycerols: a lipidomic window on diet and disease.</gtr:title><gtr:parentPublicationTitle>Biochemical Society transactions</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4d0e3ad7533d1f938a8e188b5620f00a"><gtr:id>4d0e3ad7533d1f938a8e188b5620f00a</gtr:id><gtr:otherNames>Sanders F</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0300-5127</gtr:issn><gtr:outcomeId>585d510c08eb10.54438350</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1DC1EE69-2D60-4DD4-9D95-223F96646005</gtr:id><gtr:title>MetaboLights: An Open-Access Database Repository for Metabolomics Data.</gtr:title><gtr:parentPublicationTitle>Current protocols in bioinformatics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1c57afb01c107304176a8da6715507ec"><gtr:id>1c57afb01c107304176a8da6715507ec</gtr:id><gtr:otherNames>Kale NS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1934-3396</gtr:issn><gtr:outcomeId>58bd343f72a949.27554067</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BA3CC77A-DBC7-4785-837A-76367EACCC68</gtr:id><gtr:title>MetaboLights--an open-access general-purpose repository for metabolomics studies and associated meta-data.</gtr:title><gtr:parentPublicationTitle>Nucleic acids research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e768fabb0ec5c84e9603d642ff6e3263"><gtr:id>e768fabb0ec5c84e9603d642ff6e3263</gtr:id><gtr:otherNames>Haug K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0305-1048</gtr:issn><gtr:outcomeId>pm_13207_27_23109552</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>723F9EA7-A9F3-4BE5-B7E2-F5CA32BEB513</gtr:id><gtr:title>Differential translocation of the fatty acid transporter, FAT/CD36, and the glucose transporter, GLUT4, coordinates changes in cardiac substrate metabolism during ischemia and reperfusion.</gtr:title><gtr:parentPublicationTitle>Circulation. Heart failure</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2aafcacfdc2b9b717a966c8e44df802e"><gtr:id>2aafcacfdc2b9b717a966c8e44df802e</gtr:id><gtr:otherNames>Heather LC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1941-3289</gtr:issn><gtr:outcomeId>pm_13207_27_23940308</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9BE08673-1E82-44D7-99E3-D74AD0EB6F33</gtr:id><gtr:title>A combination of plasma phospholipid fatty acids and its association with incidence of type 2 diabetes: The EPIC-InterAct case-cohort study.</gtr:title><gtr:parentPublicationTitle>PLoS medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/559516d0363462c4be489a2a8792a28f"><gtr:id>559516d0363462c4be489a2a8792a28f</gtr:id><gtr:otherNames>Imamura F</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1549-1277</gtr:issn><gtr:outcomeId>5a6169d209d769.93585852</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>96FF32EC-49A1-4298-99BC-8C6FB8C87F12</gtr:id><gtr:title>Hyphenating size-exclusion chromatography with electrospray mass spectrometry; using on-line liquid-liquid extraction to study the lipid composition of lipoprotein particles.</gtr:title><gtr:parentPublicationTitle>Rapid communications in mass spectrometry : RCM</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/960462874c9da9ea24bdb5bdb2e6d469"><gtr:id>960462874c9da9ea24bdb5bdb2e6d469</gtr:id><gtr:otherNames>Osei M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0951-4198</gtr:issn><gtr:outcomeId>56bb67e5def017.50688243</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>64E05868-5A77-4559-B046-8D53273BC738</gtr:id><gtr:title>C13orf31 (FAMIN) is a central regulator of immunometabolic function.</gtr:title><gtr:parentPublicationTitle>Nature immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/32711005bbbc3c895889b86f934b0688"><gtr:id>32711005bbbc3c895889b86f934b0688</gtr:id><gtr:otherNames>Cader MZ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1529-2908</gtr:issn><gtr:outcomeId>58bd343e7af4f8.91400556</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E9DE3BD7-E0A8-4D02-BDC1-2D1EA708D876</gtr:id><gtr:title>Nitrate enhances skeletal muscle fatty acid oxidation via a nitric oxide-cGMP-PPAR-mediated mechanism.</gtr:title><gtr:parentPublicationTitle>BMC biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/22ed715a0fd2d6b6675acaed09c2c5c8"><gtr:id>22ed715a0fd2d6b6675acaed09c2c5c8</gtr:id><gtr:otherNames>Ashmore T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1741-7007</gtr:issn><gtr:outcomeId>56bb5ecb8e34d9.07984408</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>988C9440-ACA1-4833-B00D-1A6B750EC21A</gtr:id><gtr:title>Statistical Health Monitoring Applied to a Metabolomic Study of Experimental Hepatocarcinogenesis: An Alternative Approach to Supervised Methods for the Identification of False Positives.</gtr:title><gtr:parentPublicationTitle>Analytical chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0f38801c583abf138dba148152d5d8dc"><gtr:id>0f38801c583abf138dba148152d5d8dc</gtr:id><gtr:otherNames>Del Carratore F</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0003-2700</gtr:issn><gtr:outcomeId>58bd343ec6cbd8.55763282</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E1CFAE51-4C8A-4455-9C32-7B9E666A49E0</gtr:id><gtr:title>Hypoxic regulation of hand1 controls the fetal-neonatal switch in cardiac metabolism.</gtr:title><gtr:parentPublicationTitle>PLoS biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/daf342954ef6f15c10706d127234ee8b"><gtr:id>daf342954ef6f15c10706d127234ee8b</gtr:id><gtr:otherNames>Breckenridge RA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1544-9173</gtr:issn><gtr:outcomeId>pm_13207_27_24086110</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9F5CD237-770C-4FCF-996C-C4A4F1179E9C</gtr:id><gtr:title>IsotopicLabelling: an R package for the analysis of MS isotopic patterns of labelled analytes.</gtr:title><gtr:parentPublicationTitle>Bioinformatics (Oxford, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f458f52928a4d2c86d97921db4840720"><gtr:id>f458f52928a4d2c86d97921db4840720</gtr:id><gtr:otherNames>Ferrazza R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1367-4803</gtr:issn><gtr:outcomeId>58bd343e2d0a52.14293882</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F35D09B7-E6AD-4FDF-BF82-DB0B28538818</gtr:id><gtr:title>Metabolomic analysis of akt1-mediated muscle hypertrophy in models of diet-induced obesity and age-related fat accumulation.</gtr:title><gtr:parentPublicationTitle>Journal of proteome research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/47a9d7dce5538e596430582873002614"><gtr:id>47a9d7dce5538e596430582873002614</gtr:id><gtr:otherNames>Cheng KK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1535-3893</gtr:issn><gtr:outcomeId>5462078f559ce0.59045992</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5EBD396C-5E40-4322-8F88-7D560514E5CC</gtr:id><gtr:title>Novel ketone diet enhances physical and cognitive performance.</gtr:title><gtr:parentPublicationTitle>FASEB journal : official publication of the Federation of American Societies for Experimental Biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ac60c126dd05fe5ce69dfda4816f4de9"><gtr:id>ac60c126dd05fe5ce69dfda4816f4de9</gtr:id><gtr:otherNames>Murray AJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0892-6638</gtr:issn><gtr:outcomeId>58bd343e5b1e88.95303624</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7417EFC5-A209-45AC-9FF9-EBF00345EB66</gtr:id><gtr:title>Computational tools and workflows in metabolomics: An international survey highlights the opportunity for harmonisation through Galaxy.</gtr:title><gtr:parentPublicationTitle>Metabolomics : Official journal of the Metabolomic Society</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e28e53f277d1c67666af32ab74388426"><gtr:id>e28e53f277d1c67666af32ab74388426</gtr:id><gtr:otherNames>Weber RJM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1573-3882</gtr:issn><gtr:outcomeId>58bd343d3bb2c3.20946173</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>57FA4308-1DE7-4784-97C3-6EB0A20F07BD</gtr:id><gtr:title>Metabolomics dataset of PPAR-pan treated rat liver.</gtr:title><gtr:parentPublicationTitle>Data in brief</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/605afa4d43c7798be6ab908c49549eb0"><gtr:id>605afa4d43c7798be6ab908c49549eb0</gtr:id><gtr:otherNames>Ament Z</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2352-3409</gtr:issn><gtr:outcomeId>585d342e7f2a86.40199431</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>87FCE2B2-D02C-496F-9F9F-12A7E042E907</gtr:id><gtr:title>A targeted metabolomics assay for cardiac metabolism and demonstration using a mouse model of dilated cardiomyopathy.</gtr:title><gtr:parentPublicationTitle>Metabolomics : Official journal of the Metabolomic Society</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/60c46c8b27756d4e59f65028a7eb54f2"><gtr:id>60c46c8b27756d4e59f65028a7eb54f2</gtr:id><gtr:otherNames>West JA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1573-3882</gtr:issn><gtr:outcomeId>585d3305e204a7.97151705</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F6E79018-74EF-4457-ADAD-73302EDE3C17</gtr:id><gtr:title>Assessing Cardiac Metabolism: A Scientific Statement From the American Heart Association.</gtr:title><gtr:parentPublicationTitle>Circulation research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3d6d2388cc5de7578f7aeba3e818c521"><gtr:id>3d6d2388cc5de7578f7aeba3e818c521</gtr:id><gtr:otherNames>Taegtmeyer H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0009-7330</gtr:issn><gtr:outcomeId>58bd343f43c744.00883565</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4BB21D0D-0587-4F3B-B6CE-0C490BAB84EE</gtr:id><gtr:title>The use of stable isotopes in the study of human pathophysiology.</gtr:title><gtr:parentPublicationTitle>The international journal of biochemistry &amp; cell biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d27da3441cd4f99b4649723f2b52b490"><gtr:id>d27da3441cd4f99b4649723f2b52b490</gtr:id><gtr:otherNames>Charidemou E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1357-2725</gtr:issn><gtr:outcomeId>5a9ebf63a04339.66378789</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4823BF96-A525-412D-8FC1-D835F8AC08FC</gtr:id><gtr:title>A new role for lipocalin prostaglandin d synthase in the regulation of brown adipose tissue substrate utilization.</gtr:title><gtr:parentPublicationTitle>Diabetes</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e137cbde914442352a009c77419799ba"><gtr:id>e137cbde914442352a009c77419799ba</gtr:id><gtr:otherNames>Virtue S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0012-1797</gtr:issn><gtr:outcomeId>pm_13207_27_22923471</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>90123539-EA9F-4EC6-B0FD-3C0A7E7F039F</gtr:id><gtr:title>A study of Caenorhabditis elegans DAF-2 mutants by metabolomics and differential correlation networks.</gtr:title><gtr:parentPublicationTitle>Molecular bioSystems</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/91d7098c12f9ac872ccb48d93bd0b20a"><gtr:id>91d7098c12f9ac872ccb48d93bd0b20a</gtr:id><gtr:otherNames>Castro C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1742-2051</gtr:issn><gtr:outcomeId>pm_13207_27_23475189</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9AA5CF7D-888A-400F-9A6C-EE3892442D63</gtr:id><gtr:title>Metabolomics as a tool for cardiac research.</gtr:title><gtr:parentPublicationTitle>Nature reviews. Cardiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d0fa52afc678c4e6d52598c663a0af7a"><gtr:id>d0fa52afc678c4e6d52598c663a0af7a</gtr:id><gtr:otherNames>Griffin JL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1759-5002</gtr:issn><gtr:outcomeId>pm_5435afd5afde2db27</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>09361874-5FED-48DF-A0E3-408AB999EDC5</gtr:id><gtr:title>The potential of Ion Mobility Mass Spectrometry for high-throughput and high-resolution lipidomics.</gtr:title><gtr:parentPublicationTitle>Current opinion in chemical biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1bb0d25d176ae3afe2d47c225bf74727"><gtr:id>1bb0d25d176ae3afe2d47c225bf74727</gtr:id><gtr:otherNames>Hinz C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2018-01-01</gtr:date><gtr:issn>1367-5931</gtr:issn><gtr:outcomeId>5a616de7f0bdb2.14915932</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8BAEE1F7-026C-49DD-842C-594F917CE2DA</gtr:id><gtr:title>Epidemiological transition of colorectal cancer in developing countries: environmental factors, molecular pathways, and opportunities for prevention.</gtr:title><gtr:parentPublicationTitle>World journal of gastroenterology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e8bb299a8b44bbc93de465568fdeec56"><gtr:id>e8bb299a8b44bbc93de465568fdeec56</gtr:id><gtr:otherNames>Bishehsari F</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1007-9327</gtr:issn><gtr:outcomeId>5461fb532393b9.85428440</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4FE658C6-6466-45F1-A05F-5A1ADE2AE85E</gtr:id><gtr:title>Regulation of mitochondrial morphology and function by stearoylation of TFR1.</gtr:title><gtr:parentPublicationTitle>Nature</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/79ebcc3b3a811bc866b680f632d96c20"><gtr:id>79ebcc3b3a811bc866b680f632d96c20</gtr:id><gtr:otherNames>Senyilmaz D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0028-0836</gtr:issn><gtr:outcomeId>56bb67e64dba00.68005044</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B12BDBEC-F7CC-44A8-BE15-E3B3B6057965</gtr:id><gtr:title>Mechanistic insights revealed by lipid profiling in monogenic insulin resistance syndromes.</gtr:title><gtr:parentPublicationTitle>Genome medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/dbf95ec29a8570e7cba45b6531f6cb39"><gtr:id>dbf95ec29a8570e7cba45b6531f6cb39</gtr:id><gtr:otherNames>Eiden M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1756-994X</gtr:issn><gtr:outcomeId>5675ea317920f</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9F580B28-FDCE-4A8F-B53B-DC6421B68D0B</gtr:id><gtr:title>Mitochondrial responses to extreme environments: insights from metabolomics.</gtr:title><gtr:parentPublicationTitle>Extreme physiology &amp; medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a0af47387552a70f2ff4149b07e79c6e"><gtr:id>a0af47387552a70f2ff4149b07e79c6e</gtr:id><gtr:otherNames>O'Brien KA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>2046-7648</gtr:issn><gtr:outcomeId>56bb67e6d8b944.43061417</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CA63E031-B6E4-4C2A-86CA-EE5740BFEDF9</gtr:id><gtr:title>Brown Adipose Tissue Thermogenic Capacity Is Regulated by Elovl6.</gtr:title><gtr:parentPublicationTitle>Cell reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5b0fe1561e92f157420919eb81c6a910"><gtr:id>5b0fe1561e92f157420919eb81c6a910</gtr:id><gtr:otherNames>Tan CY</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:outcomeId>56bb67e5619e62.67929974</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A3550CCC-EEB1-4685-8B83-C7267C076574</gtr:id><gtr:title>Cross sectional evaluation of the gut-microbiome metabolome axis in an Italian cohort of IBD patients.</gtr:title><gtr:parentPublicationTitle>Scientific reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c703163e3aa70a62511439aa526fa721"><gtr:id>c703163e3aa70a62511439aa526fa721</gtr:id><gtr:otherNames>Santoru ML</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>2045-2322</gtr:issn><gtr:outcomeId>5a616e0a4795b3.25795800</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EEBCC614-579D-4305-9526-A0ED646BF1E0</gtr:id><gtr:title>Inorganic Nitrate Mimics Exercise-Stimulated Muscular Fiber-Type Switching and Myokine and ?-Aminobutyric Acid Release.</gtr:title><gtr:parentPublicationTitle>Diabetes</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/59b6e3728c2503ea027017abe00a44c7"><gtr:id>59b6e3728c2503ea027017abe00a44c7</gtr:id><gtr:otherNames>Roberts LD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0012-1797</gtr:issn><gtr:outcomeId>58bd343d5bdeb0.05572698</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1BC09688-CD67-4D24-B34A-B76A23A012B0</gtr:id><gtr:title>PPAR-pan activation induces hepatic oxidative stress and lipidomic remodelling.</gtr:title><gtr:parentPublicationTitle>Free radical biology &amp; medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/605afa4d43c7798be6ab908c49549eb0"><gtr:id>605afa4d43c7798be6ab908c49549eb0</gtr:id><gtr:otherNames>Ament Z</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0891-5849</gtr:issn><gtr:outcomeId>56bb5ecc443a80.79856525</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BF2DF74F-2D72-4F06-85A6-B3CBBF7084CD</gtr:id><gtr:title>Comprehensive overexpression analysis of cyclic-di-GMP signalling proteins in the phytopathogen Pectobacterium atrosepticum reveals diverse effects on motility and virulence phenotypes.</gtr:title><gtr:parentPublicationTitle>Microbiology (Reading, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b1aa89b18fc70f0ebcbb8e32c8bdb953"><gtr:id>b1aa89b18fc70f0ebcbb8e32c8bdb953</gtr:id><gtr:otherNames>Tan H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1350-0872</gtr:issn><gtr:outcomeId>5461fb52cf4322.16791764</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0D3C8A16-5A13-4443-AF8F-663929028DCE</gtr:id><gtr:title>Lipidomics Profiling of Human Adipose Tissue Identifies a Pattern of Lipids Associated with Fish Oil Supplementation.</gtr:title><gtr:parentPublicationTitle>Journal of proteome research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/20eb75875233be60137d23bb1ac0c01c"><gtr:id>20eb75875233be60137d23bb1ac0c01c</gtr:id><gtr:otherNames>Stanley EG</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1535-3893</gtr:issn><gtr:outcomeId>5a2fcff028d460.76924217</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3DCC516C-2CBD-4336-ACB1-4D51E786E7B3</gtr:id><gtr:title>Transcription factor Nrf1 negatively regulates the cystine/glutamate transporter and lipid-metabolizing enzymes.</gtr:title><gtr:parentPublicationTitle>Molecular and cellular biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c1b5b6b67f96413edf0935d3f861a2e6"><gtr:id>c1b5b6b67f96413edf0935d3f861a2e6</gtr:id><gtr:otherNames>Tsujita T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0270-7306</gtr:issn><gtr:outcomeId>5461fb52f31b85.21829545</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4319078B-937C-4AC9-B1D5-C7B5C84F5735</gtr:id><gtr:title>Mechanisms of Vascular Dysfunction in COPD and Effects of a Novel Soluble Epoxide Hydrolase Inhibitor in Smokers.</gtr:title><gtr:parentPublicationTitle>Chest</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/567a6df44fe9ec1809d4232be794446a"><gtr:id>567a6df44fe9ec1809d4232be794446a</gtr:id><gtr:otherNames>Yang L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0012-3692</gtr:issn><gtr:outcomeId>58bd343dcb2256.23601859</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5AB767F2-4186-49A7-B086-8D14016B239F</gtr:id><gtr:title>Dietary nitrate increases arginine availability and protects mitochondrial complex I and energetics in the hypoxic rat heart.</gtr:title><gtr:parentPublicationTitle>The Journal of physiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/22ed715a0fd2d6b6675acaed09c2c5c8"><gtr:id>22ed715a0fd2d6b6675acaed09c2c5c8</gtr:id><gtr:otherNames>Ashmore T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0022-3751</gtr:issn><gtr:outcomeId>5461fa88b86409.31688175</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4ADD2C8E-5316-4B9F-AC3C-59C31A20F2E7</gtr:id><gtr:title>Toward interoperable bioscience data.</gtr:title><gtr:parentPublicationTitle>Nature genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9b64554f8b918cfdf459e6376a30b6c3"><gtr:id>9b64554f8b918cfdf459e6376a30b6c3</gtr:id><gtr:otherNames>Sansone SA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1061-4036</gtr:issn><gtr:outcomeId>pm_13207_27_22281772</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0EDB2FA8-225B-4D3D-BA77-258656B271C7</gtr:id><gtr:title>Erratum: Adipose tissue fatty acid chain length and mono-unsaturation increases with obesity and insulin resistance.</gtr:title><gtr:parentPublicationTitle>Scientific reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5b0fe1561e92f157420919eb81c6a910"><gtr:id>5b0fe1561e92f157420919eb81c6a910</gtr:id><gtr:otherNames>Tan CY</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2045-2322</gtr:issn><gtr:outcomeId>58bd343f1d6077.99147528</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A9583B33-5630-494A-A5BD-93DB9F421436</gtr:id><gtr:title>Impaired in vivo mitochondrial Krebs cycle activity after myocardial infarction assessed using hyperpolarized magnetic resonance spectroscopy.</gtr:title><gtr:parentPublicationTitle>Circulation. Cardiovascular imaging</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ee305b12ca3112f382a7d704638034f9"><gtr:id>ee305b12ca3112f382a7d704638034f9</gtr:id><gtr:otherNames>Dodd MS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1941-9651</gtr:issn><gtr:outcomeId>5462078fa4b9f7.92591847</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>87FFA3A7-3074-4B0A-965C-61E3E0D158D3</gtr:id><gtr:title>Inhibition of sarcolemmal FAT/CD36 by sulfo-N-succinimidyl oleate rapidly corrects metabolism and restores function in the diabetic heart following hypoxia/reoxygenation.</gtr:title><gtr:parentPublicationTitle>Cardiovascular research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/eaac6efc47275d4a129d800b10603fae"><gtr:id>eaac6efc47275d4a129d800b10603fae</gtr:id><gtr:otherNames>Mansor LS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0008-6363</gtr:issn><gtr:outcomeId>5a61680b12c5c9.19825464</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7D8168AC-82B8-4A9F-BB91-95458FD9CA8A</gtr:id><gtr:title>The contrasting roles of PPARd and PPAR? in regulating the metabolic switch between oxidation and storage of fats in white adipose tissue.</gtr:title><gtr:parentPublicationTitle>Genome biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/59b6e3728c2503ea027017abe00a44c7"><gtr:id>59b6e3728c2503ea027017abe00a44c7</gtr:id><gtr:otherNames>Roberts LD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1474-7596</gtr:issn><gtr:outcomeId>pm_5435afd5afdedec6b</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9A6B5DA5-0C02-4E4C-9E25-B06E04F06B9E</gtr:id><gtr:title>Association between sucrose intake and risk of overweight and obesity in a prospective sub-cohort of the European Prospective Investigation into Cancer in Norfolk (EPIC-Norfolk).</gtr:title><gtr:parentPublicationTitle>Public health nutrition</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/304e66d8922856234eb585ca601d6e5c"><gtr:id>304e66d8922856234eb585ca601d6e5c</gtr:id><gtr:otherNames>Kuhnle GG</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1368-9800</gtr:issn><gtr:outcomeId>56bb67e80b8359.95981421</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B382A40E-F512-4126-B0E3-E687865DC48B</gtr:id><gtr:title>Differences in the prospective association between individual plasma phospholipid saturated fatty acids and incident type 2 diabetes: the EPIC-InterAct case-cohort study.</gtr:title><gtr:parentPublicationTitle>The lancet. Diabetes &amp; endocrinology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5d49fb8098ab21616c9235687213475f"><gtr:id>5d49fb8098ab21616c9235687213475f</gtr:id><gtr:otherNames>Forouhi NG</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>2213-8587</gtr:issn><gtr:outcomeId>5461fa88eaec47.80643213</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>27CA5931-34FA-4E1A-9A82-DB797AA7FA0E</gtr:id><gtr:title>The mitochondria-targeted antioxidant MitoQ decreases features of the metabolic syndrome in ATM+/-/ApoE-/- mice.</gtr:title><gtr:parentPublicationTitle>Free radical biology &amp; medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d99dba47d76894312570ea1e6933c814"><gtr:id>d99dba47d76894312570ea1e6933c814</gtr:id><gtr:otherNames>Mercer JR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0891-5849</gtr:issn><gtr:outcomeId>WXeg3NwRbVe</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>17A32707-8CAA-42E2-93B2-0CEB467D2325</gtr:id><gtr:title>A practical guide to metabolomic profiling as a discovery tool for human heart disease.</gtr:title><gtr:parentPublicationTitle>Journal of molecular and cellular cardiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2aafcacfdc2b9b717a966c8e44df802e"><gtr:id>2aafcacfdc2b9b717a966c8e44df802e</gtr:id><gtr:otherNames>Heather LC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0022-2828</gtr:issn><gtr:outcomeId>pm_13207_27_23231771</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>684DE167-37D7-4B2A-9E04-2D822A14BFAF</gtr:id><gtr:title>Association between plasma phospholipid saturated fatty acids and metabolic markers of lipid, hepatic, inflammation and glycaemic pathways in eight European countries: a cross-sectional analysis in the EPIC-InterAct study.</gtr:title><gtr:parentPublicationTitle>BMC medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/96ed4c140d487c8ab44c0ba517fb7439"><gtr:id>96ed4c140d487c8ab44c0ba517fb7439</gtr:id><gtr:otherNames>Zheng JS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1741-7015</gtr:issn><gtr:outcomeId>5a2fd79e3d21f3.87980252</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>785DC5E1-3F6D-4E83-8175-57890C3B4CE9</gtr:id><gtr:title>Adaptive changes of the Insig1/SREBP1/SCD1 set point help adipose tissue to cope with increased storage demands of obesity.</gtr:title><gtr:parentPublicationTitle>Diabetes</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f3098d46384b300a0dd4b590e33f76cd"><gtr:id>f3098d46384b300a0dd4b590e33f76cd</gtr:id><gtr:otherNames>Carobbio S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0012-1797</gtr:issn><gtr:outcomeId>pm_13207_27_23919961</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B7D8BBCD-F4D4-4D28-9E1B-7560EDC6F8E2</gtr:id><gtr:title>Biomarkers of food intake and metabolite differences between plasma and red blood cell matrices; a human metabolomic profile approach.</gtr:title><gtr:parentPublicationTitle>Molecular bioSystems</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e9a825e5899498c8f94579f6c5c06c86"><gtr:id>e9a825e5899498c8f94579f6c5c06c86</gtr:id><gtr:otherNames>Catal?n ?</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1742-2051</gtr:issn><gtr:outcomeId>pm_13207_27_23493899</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5006F1BD-E7DF-41F3-828B-7061DC3465F9</gtr:id><gtr:title>Metabolic basis to Sherpa altitude adaptation.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ca72925f0dfe24b3e04ec9075b1eabf3"><gtr:id>ca72925f0dfe24b3e04ec9075b1eabf3</gtr:id><gtr:otherNames>Horscroft JA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn><gtr:outcomeId>5a9ebf63c6bca4.00966987</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3DFAF69C-28B1-4DE6-924D-9B435CEC0EA3</gtr:id><gtr:title>Vascular dysfunction induced in offspring by maternal dietary fat involves altered arterial polyunsaturated fatty acid biosynthesis.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/070b9110a3f25cc5d9f71611e38e4e2a"><gtr:id>070b9110a3f25cc5d9f71611e38e4e2a</gtr:id><gtr:otherNames>Kelsall CJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>pm_13207_27_22509311</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>10ABF308-25D9-4BCD-AFBA-0F4F45242F3E</gtr:id><gtr:title>Prostaglandin profiling reveals a role for haematopoietic prostaglandin D synthase in adipose tissue macrophage polarisation in mice and humans.</gtr:title><gtr:parentPublicationTitle>International journal of obesity (2005)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e137cbde914442352a009c77419799ba"><gtr:id>e137cbde914442352a009c77419799ba</gtr:id><gtr:otherNames>Virtue S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0307-0565</gtr:issn><gtr:outcomeId>56bb67e7a96589.82505349</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>45868CA0-13BF-405A-BCC9-C5647C1056DD</gtr:id><gtr:title>An extracellular siderophore is required to maintain the mutualistic interaction of Epichlo&amp;euml; festucae with Lolium perenne.</gtr:title><gtr:parentPublicationTitle>PLoS pathogens</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/593547173e2ff230fa8be5a1acd971c6"><gtr:id>593547173e2ff230fa8be5a1acd971c6</gtr:id><gtr:otherNames>Johnson LJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1553-7366</gtr:issn><gtr:outcomeId>5461fa891cd471.04070316</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>16EECA02-E875-4298-8363-EE2BCB6246BB</gtr:id><gtr:title>Ask not what data standards can do for you but what you can do for data standards: a personal view of reporting standardisation in metabolomic experiments</gtr:title><gtr:parentPublicationTitle>Metabolomics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/954d87bb5653f09b11cdfadd678ef439"><gtr:id>954d87bb5653f09b11cdfadd678ef439</gtr:id><gtr:otherNames>Griffin J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:outcomeId>doi_13207_011_0312_5</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>16920F68-FD65-4ABE-91B6-0C87B9A65A36</gtr:id><gtr:title>Post-developmental microRNA expression is required for normal physiology, and regulates aging in parallel to insulin/IGF-1 signaling in C. elegans.</gtr:title><gtr:parentPublicationTitle>RNA (New York, N.Y.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2f74c8a43bb2ffd9211ede936f8a0890"><gtr:id>2f74c8a43bb2ffd9211ede936f8a0890</gtr:id><gtr:otherNames>Lehrbach NJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1355-8382</gtr:issn><gtr:outcomeId>pm_13207_27_23097426</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4AD529EE-DB47-4784-97D1-5CB4A924EC9D</gtr:id><gtr:title>Lipocalin prostaglandin D synthase and PPAR?2 coordinate to regulate carbohydrate and lipid metabolism in vivo.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e137cbde914442352a009c77419799ba"><gtr:id>e137cbde914442352a009c77419799ba</gtr:id><gtr:otherNames>Virtue S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>pm_13207_27_22792179</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9D0B1CF6-7A8B-4563-B778-613F8087FE4B</gtr:id><gtr:title>Design and cohort description of the InterAct Project: an examination of the interaction of genetic and lifestyle factors on the incidence of type 2 diabetes in the EPIC Study.</gtr:title><gtr:parentPublicationTitle>Diabetologia</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3910f4e5f22b59f0f4314fa19d594e18"><gtr:id>3910f4e5f22b59f0f4314fa19d594e18</gtr:id><gtr:otherNames>InterAct Consortium</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0012-186X</gtr:issn><gtr:outcomeId>pm_13207_27_21717116</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>67F5CAFA-676D-4AC5-949D-4C194C9BEB6F</gtr:id><gtr:title>An open-label study to assess the feasibility and tolerability of rilmenidine for the treatment of Huntington's disease.</gtr:title><gtr:parentPublicationTitle>Journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1b957f5c686493ef530aa6c8d8777989"><gtr:id>1b957f5c686493ef530aa6c8d8777989</gtr:id><gtr:otherNames>Underwood BR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0340-5354</gtr:issn><gtr:outcomeId>5a617078afc4d8.77417210</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B4DD6B12-B571-4801-86DF-17214DE89907</gtr:id><gtr:title>Conditional iron and pH-dependent activity of a non-enzymatic glycolysis and pentose phosphate pathway.</gtr:title><gtr:parentPublicationTitle>Science advances</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5149a121f677d68e7b082a47844fd987"><gtr:id>5149a121f677d68e7b082a47844fd987</gtr:id><gtr:otherNames>Keller MA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2375-2548</gtr:issn><gtr:outcomeId>56bb5ecb039402.89713031</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A0BB4395-D626-4245-A31B-97AE37EE7E38</gtr:id><gtr:title>A role for vaccinia virus protein C16 in reprogramming cellular energy metabolism.</gtr:title><gtr:parentPublicationTitle>The Journal of general virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0891438d816cafe947eb99b11ba8213f"><gtr:id>0891438d816cafe947eb99b11ba8213f</gtr:id><gtr:otherNames>Mazzon M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0022-1317</gtr:issn><gtr:outcomeId>546206da221825.01101718</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E184B4FB-5515-4301-AF70-BC5165FD5D95</gtr:id><gtr:title>Metabolomics applied to diabetes-lessons from human population studies.</gtr:title><gtr:parentPublicationTitle>The international journal of biochemistry &amp; cell biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0fe5a9be79f8adb71f25d7e98091a0aa"><gtr:id>0fe5a9be79f8adb71f25d7e98091a0aa</gtr:id><gtr:otherNames>Liggi S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1357-2725</gtr:issn><gtr:outcomeId>5a616ed3a50da1.14540118</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>079B7E93-6394-4796-8C2A-5140032A0B16</gtr:id><gtr:title>COordination of Standards in MetabOlomicS (COSMOS): facilitating integrated metabolomics data access.</gtr:title><gtr:parentPublicationTitle>Metabolomics : Official journal of the Metabolomic Society</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/dae631a3576f009bac122d1667e53a1d"><gtr:id>dae631a3576f009bac122d1667e53a1d</gtr:id><gtr:otherNames>Salek RM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1573-3882</gtr:issn><gtr:outcomeId>56bb67e59df692.15811146</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EAD025AF-A168-48F3-A3CE-1FCE835C4AA2</gtr:id><gtr:title>MetaboLights: towards a new COSMOS of metabolomics data management.</gtr:title><gtr:parentPublicationTitle>Metabolomics : Official journal of the Metabolomic Society</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1be609d9f95b2529fa2f9735298d6d95"><gtr:id>1be609d9f95b2529fa2f9735298d6d95</gtr:id><gtr:otherNames>Steinbeck C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1573-3882</gtr:issn><gtr:outcomeId>pm_13207_27_23060735</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6F9F71AD-19FE-449B-A72C-9B097336DEA6</gtr:id><gtr:title>Alphavirus-induced hyperactivation of PI3K/AKT directs pro-viral metabolic changes.</gtr:title><gtr:parentPublicationTitle>PLoS pathogens</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0891438d816cafe947eb99b11ba8213f"><gtr:id>0891438d816cafe947eb99b11ba8213f</gtr:id><gtr:otherNames>Mazzon M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2018-01-01</gtr:date><gtr:issn>1553-7366</gtr:issn><gtr:outcomeId>5a995f0cbfadd2.63234865</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3F38E023-CD27-4772-A99D-38980B6B4F03</gtr:id><gtr:title>Omega-3 PUFA supplementation and the response to evoked endotoxemia in healthy volunteers.</gtr:title><gtr:parentPublicationTitle>Molecular nutrition &amp; food research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a87c693123aa2ea668dffbc177a9e54c"><gtr:id>a87c693123aa2ea668dffbc177a9e54c</gtr:id><gtr:otherNames>Ferguson JF</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1613-4125</gtr:issn><gtr:outcomeId>pm_13207_27_24190860</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>53AF1F49-4FF4-494F-8708-44DBC03C9901</gtr:id><gtr:title>: an R package for annotation and interpretation of mass spectrometry imaging data for lipidomics.</gtr:title><gtr:parentPublicationTitle>Metabolomics : Official journal of the Metabolomic Society</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5ee0d60d78393d2009f599de39991f30"><gtr:id>5ee0d60d78393d2009f599de39991f30</gtr:id><gtr:otherNames>Bond NJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1573-3882</gtr:issn><gtr:outcomeId>5a616d8a75c4c2.58309103</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8A6F9658-12C8-4E9E-B77A-941D924425AF</gtr:id><gtr:title>Suppression of erythropoiesis by dietary nitrate.</gtr:title><gtr:parentPublicationTitle>FASEB journal : official publication of the Federation of American Societies for Experimental Biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/22ed715a0fd2d6b6675acaed09c2c5c8"><gtr:id>22ed715a0fd2d6b6675acaed09c2c5c8</gtr:id><gtr:otherNames>Ashmore T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0892-6638</gtr:issn><gtr:outcomeId>56bb67e881b882.72131980</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7571283D-5F05-462F-BA14-0F42A86CC38A</gtr:id><gtr:title>Obesity in mice with adipocyte-specific deletion of clock component Arntl.</gtr:title><gtr:parentPublicationTitle>Nature medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/31cd347f1788091e7e6d2fe14ea9eec4"><gtr:id>31cd347f1788091e7e6d2fe14ea9eec4</gtr:id><gtr:otherNames>Paschos GK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1078-8956</gtr:issn><gtr:outcomeId>pm_13207_27_23142819</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0066C469-35DC-465B-BF4C-801B3110764D</gtr:id><gtr:title>Nutritional Ketosis Alters Fuel Preference and Thereby Endurance Performance in Athletes.</gtr:title><gtr:parentPublicationTitle>Cell metabolism</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/67be2475aac9535fc2f1fb52d61463db"><gtr:id>67be2475aac9535fc2f1fb52d61463db</gtr:id><gtr:otherNames>Cox PJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1550-4131</gtr:issn><gtr:outcomeId>58bd343ea469f8.47801649</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>98921645-3F41-46EF-B339-11177A22556D</gtr:id><gtr:title>Hematopoietic IKBKE limits the chronicity of inflammasome priming and metaflammation.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d6013e7c1934b6d55026ed02e21ab0c8"><gtr:id>d6013e7c1934b6d55026ed02e21ab0c8</gtr:id><gtr:otherNames>Patel MN</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn><gtr:outcomeId>56bb67e8467268.42426177</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DE2884E3-A2C0-46D3-BE54-B1174282C958</gtr:id><gtr:title>Clustering nuclear receptors in liver regeneration identifies candidate modulators of hepatocyte proliferation and hepatocarcinoma.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7fe0043d25a0888851cac9f3a9f58eb4"><gtr:id>7fe0043d25a0888851cac9f3a9f58eb4</gtr:id><gtr:otherNames>Vacca M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>5461fb5372f343.09753179</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F745D9FC-052B-4BF4-BECE-6A3E6FFDAF2E</gtr:id><gtr:title>Myc Expression Drives Aberrant Lipid Metabolism in Lung Cancer.</gtr:title><gtr:parentPublicationTitle>Cancer research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8face52ad7d0211d931dd00159b1afe3"><gtr:id>8face52ad7d0211d931dd00159b1afe3</gtr:id><gtr:otherNames>Hall Z</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0008-5472</gtr:issn><gtr:outcomeId>58bd343ee3e5d2.03114557</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9FBBCBF7-6D3F-4FD5-BCA2-43B91395E355</gtr:id><gtr:title>Metabolomic and Lipidomic Analysis of the Heart of Peroxisome Proliferator-Activated Receptor-? Coactivator 1-? Knock Out Mice on a High Fat Diet.</gtr:title><gtr:parentPublicationTitle>Metabolites</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b585bf1516c05f6a9be3e70e46ebe277"><gtr:id>b585bf1516c05f6a9be3e70e46ebe277</gtr:id><gtr:otherNames>McCombie G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>2218-1989</gtr:issn><gtr:outcomeId>doi_13207_abo2020366</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B18B172C-EA5A-4D10-A860-CA7299CDCD6E</gtr:id><gtr:title>Metabolomics and Lipidomics Study of Mouse Models of Type 1 Diabetes Highlights Divergent Metabolism in Purine and Tryptophan Metabolism Prior to Disease Onset.</gtr:title><gtr:parentPublicationTitle>Journal of proteome research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/dd8694d8dd25bab9b405f0381236ad89"><gtr:id>dd8694d8dd25bab9b405f0381236ad89</gtr:id><gtr:otherNames>Murfitt SA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2018-01-01</gtr:date><gtr:issn>1535-3893</gtr:issn><gtr:outcomeId>5a995f88cbeef5.35983973</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FB97A140-9F34-4D17-88FB-3CAF3C341EC0</gtr:id><gtr:title>Quorum Sensing Is Accompanied by Global Metabolic Changes in the Opportunistic Human Pathogen Pseudomonas aeruginosa.</gtr:title><gtr:parentPublicationTitle>Journal of bacteriology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ebeaf5ef7417f04d368c600d6ed535e3"><gtr:id>ebeaf5ef7417f04d368c600d6ed535e3</gtr:id><gtr:otherNames>Davenport PW</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0021-9193</gtr:issn><gtr:outcomeId>56bb67e716cce2.25172297</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FDB7B0F8-9DBB-443E-AE92-36818CD4194C</gtr:id><gtr:title>How to bridge metabolomics and genomics.</gtr:title><gtr:parentPublicationTitle>The international journal of biochemistry &amp; cell biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/895e9c32ff4c3cc738bea475025bf496"><gtr:id>895e9c32ff4c3cc738bea475025bf496</gtr:id><gtr:otherNames>Atzori L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1357-2725</gtr:issn><gtr:outcomeId>5a9ebf63678e73.68692283</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>43BEAEB5-D841-4B73-B543-865DEDB943E6</gtr:id><gtr:title>Response to Comment on Lee et al. Diabetes 2015;64:2836-2846. Comment on Roberts et al. Diabetes 2015;64:471-484.</gtr:title><gtr:parentPublicationTitle>Diabetes</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/59b6e3728c2503ea027017abe00a44c7"><gtr:id>59b6e3728c2503ea027017abe00a44c7</gtr:id><gtr:otherNames>Roberts LD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0012-1797</gtr:issn><gtr:outcomeId>56dad0d2b395b9.10848849</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F652154F-7E01-45D7-8FB9-00581A633538</gtr:id><gtr:title>Betaine acts on a ligand-gated ion channel in the nervous system of the nematode C. elegans.</gtr:title><gtr:parentPublicationTitle>Nature neuroscience</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e4ecd04cc8cd023aca63ceed62edeb66"><gtr:id>e4ecd04cc8cd023aca63ceed62edeb66</gtr:id><gtr:otherNames>Peden AS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1097-6256</gtr:issn><gtr:outcomeId>pm_13207_27_24212673</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A3931E75-3D6F-4A3C-8B75-4FE15C05896C</gtr:id><gtr:title>Review metabolomics: a new approach to drug delivery in perinatology.</gtr:title><gtr:parentPublicationTitle>Current medicinal chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/895e9c32ff4c3cc738bea475025bf496"><gtr:id>895e9c32ff4c3cc738bea475025bf496</gtr:id><gtr:otherNames>Atzori L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0929-8673</gtr:issn><gtr:outcomeId>pm_13207_27_22876903</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2A3E2BE0-802A-4E15-8CBE-49A8376B6F58</gtr:id><gtr:title>Analysis of chloroformate-derivatised amino acids, dipeptides and polyamines by LC-MS/MS.</gtr:title><gtr:parentPublicationTitle>Journal of chromatography. B, Analytical technologies in the biomedical and life sciences</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/619a8fe02d16d22483cc100d804e6833"><gtr:id>619a8fe02d16d22483cc100d804e6833</gtr:id><gtr:otherNames>Ubhi BK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1570-0232</gtr:issn><gtr:outcomeId>pm_13207_27_23911539</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DBAE66F6-92D3-4DD9-BC2F-7E31E74F07C9</gtr:id><gtr:title>Does our gut microbiome predict cardiovascular risk? A review of the evidence from metabolomics.</gtr:title><gtr:parentPublicationTitle>Circulation. Cardiovascular genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d0fa52afc678c4e6d52598c663a0af7a"><gtr:id>d0fa52afc678c4e6d52598c663a0af7a</gtr:id><gtr:otherNames>Griffin JL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1942-3268</gtr:issn><gtr:outcomeId>569d100f17068</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BA480BED-B3B8-43DF-BC2A-0D8026F8796F</gtr:id><gtr:title>Odd Chain Fatty Acids; New Insights of the Relationship Between the Gut Microbiota, Dietary Intake, Biosynthesis and Glucose Intolerance.</gtr:title><gtr:parentPublicationTitle>Scientific reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f7589f38a2facb77a58a9334d34b39b3"><gtr:id>f7589f38a2facb77a58a9334d34b39b3</gtr:id><gtr:otherNames>Jenkins BJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>2045-2322</gtr:issn><gtr:outcomeId>5a9ebf640c9528.96652850</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D155AFF7-1BD7-4BF1-9FAB-86913FAC9DB6</gtr:id><gtr:title>Inorganic nitrate promotes the browning of white adipose tissue through the nitrate-nitrite-nitric oxide pathway.</gtr:title><gtr:parentPublicationTitle>Diabetes</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/59b6e3728c2503ea027017abe00a44c7"><gtr:id>59b6e3728c2503ea027017abe00a44c7</gtr:id><gtr:otherNames>Roberts LD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0012-1797</gtr:issn><gtr:outcomeId>5462078f2e0ff6.65849134</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E640B618-1CBA-4464-B54D-93FE1E98136C</gtr:id><gtr:title>The translation of lipid profiles to nutritional biomarkers in the study of infant metabolism.</gtr:title><gtr:parentPublicationTitle>Metabolomics : Official journal of the Metabolomic Society</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5a4c5bb2295df1ba4ff1ccbe4d58a364"><gtr:id>5a4c5bb2295df1ba4ff1ccbe4d58a364</gtr:id><gtr:otherNames>Acharjee A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1573-3882</gtr:issn><gtr:outcomeId>58bd343cc679e7.03228931</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EFF2FE0D-735A-4D1F-92AC-E7C6D3894951</gtr:id><gtr:title>The development and validation of a fast and robust dried blood spot based lipid profiling method to study infant metabolism.</gtr:title><gtr:parentPublicationTitle>Metabolomics : Official journal of the Metabolomic Society</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b2cde012ec04dc74ebafa0d9e33775d9"><gtr:id>b2cde012ec04dc74ebafa0d9e33775d9</gtr:id><gtr:otherNames>Koulman A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1573-3882</gtr:issn><gtr:outcomeId>5461fa894a9d60.53095311</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>919D9E59-75C1-4E95-B638-1F31194D0E5D</gtr:id><gtr:title>From genomic medicine to precision medicine: highlights of 2015.</gtr:title><gtr:parentPublicationTitle>Genome medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/750c0140a7b00ab87f5a87557d058a37"><gtr:id>750c0140a7b00ab87f5a87557d058a37</gtr:id><gtr:otherNames>Auffray C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1756-994X</gtr:issn><gtr:outcomeId>56bb5ecac902f2.94252338</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>02554B09-FC4E-41F3-B10D-93C8C046E2DA</gtr:id><gtr:title>Dietary inorganic nitrate: From villain to hero in metabolic disease?</gtr:title><gtr:parentPublicationTitle>Molecular nutrition &amp; food research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d65a481b6ba35d1c62b7cb117ce7a205"><gtr:id>d65a481b6ba35d1c62b7cb117ce7a205</gtr:id><gtr:otherNames>McNally B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1613-4125</gtr:issn><gtr:outcomeId>56bb67e61e6db3.75353448</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0DBFEBD5-0287-4BCC-BA9C-9BB3C6122973</gtr:id><gtr:title>Lipid zonation and phospholipid remodeling in nonalcoholic fatty liver disease.</gtr:title><gtr:parentPublicationTitle>Hepatology (Baltimore, Md.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8face52ad7d0211d931dd00159b1afe3"><gtr:id>8face52ad7d0211d931dd00159b1afe3</gtr:id><gtr:otherNames>Hall Z</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0270-9139</gtr:issn><gtr:outcomeId>58bd343e117107.90453534</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FB1EBFD8-B1DA-46D8-97EB-D110E55D9EBA</gtr:id><gtr:title>Interlaboratory Reproducibility of a Targeted Metabolomics Platform for Analysis of Human Serum and Plasma.</gtr:title><gtr:parentPublicationTitle>Analytical chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/349eb91011e40528bfc06aa005b52db2"><gtr:id>349eb91011e40528bfc06aa005b52db2</gtr:id><gtr:otherNames>Siskos AP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0003-2700</gtr:issn><gtr:outcomeId>58bd343d7e7072.19014368</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>955AF936-7634-4997-9AC5-756F35CFA866</gtr:id><gtr:title>De novo lipogenesis in the liver in health and disease: more than just a shunting yard for glucose.</gtr:title><gtr:parentPublicationTitle>Biological reviews of the Cambridge Philosophical Society</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/40c65e61851af3447011ec6c3f3c98bd"><gtr:id>40c65e61851af3447011ec6c3f3c98bd</gtr:id><gtr:otherNames>Sanders FW</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0006-3231</gtr:issn><gtr:outcomeId>56bb67e7d335c9.84354313</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E2074974-85B2-41F1-A222-C5F154994EF4</gtr:id><gtr:title>A Metadata description of the data in &amp;quot;A metabolomic comparison of urinary changes in type 2 diabetes in mouse, rat, and human.&amp;quot;.</gtr:title><gtr:parentPublicationTitle>BMC research notes</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d0fa52afc678c4e6d52598c663a0af7a"><gtr:id>d0fa52afc678c4e6d52598c663a0af7a</gtr:id><gtr:otherNames>Griffin JL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1756-0500</gtr:issn><gtr:outcomeId>D8NBrRHYNi5</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>87A4907D-01E7-40E1-8960-63FACF5BF8CC</gtr:id><gtr:title>A type 2 biomarker separates relapsing-remitting from secondary progressive multiple sclerosis.</gtr:title><gtr:parentPublicationTitle>Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/77ed1262063e9329e3175cc70758d0fa"><gtr:id>77ed1262063e9329e3175cc70758d0fa</gtr:id><gtr:otherNames>Dickens AM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0028-3878</gtr:issn><gtr:outcomeId>546206da47a054.33875362</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FAA756B1-CA5F-44C3-8729-A9188DC4D67F</gtr:id><gtr:title>Liquid Extraction Surface Analysis Mass Spectrometry Method for Identifying the Presence and Severity of Nonalcoholic Fatty Liver Disease.</gtr:title><gtr:parentPublicationTitle>Analytical chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8face52ad7d0211d931dd00159b1afe3"><gtr:id>8face52ad7d0211d931dd00159b1afe3</gtr:id><gtr:otherNames>Hall Z</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0003-2700</gtr:issn><gtr:outcomeId>5a6167cc8bf2e2.73288531</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B06F51B7-319B-4828-9E36-C950D63409FA</gtr:id><gtr:title>Towards metabolic biomarkers of insulin resistance and type 2 diabetes: progress from the metabolome.</gtr:title><gtr:parentPublicationTitle>The lancet. Diabetes &amp; endocrinology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/59b6e3728c2503ea027017abe00a44c7"><gtr:id>59b6e3728c2503ea027017abe00a44c7</gtr:id><gtr:otherNames>Roberts LD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>2213-8587</gtr:issn><gtr:outcomeId>5461fb534dfd27.50920451</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C0979BA7-B8E6-4B0F-83BF-47E7B66EDCA6</gtr:id><gtr:title>Development and validation of a robust automated analysis of plasma phospholipid fatty acids for metabolic phenotyping of large epidemiological studies.</gtr:title><gtr:parentPublicationTitle>Genome medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5c4f200b9b5cc3765b738b5b5cb8ab47"><gtr:id>5c4f200b9b5cc3765b738b5b5cb8ab47</gtr:id><gtr:otherNames>Wang LY</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1756-994X</gtr:issn><gtr:outcomeId>pm_13207_27_23618465</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5BFB0967-7CEB-48A2-BCDB-C7D7BEF4CCCF</gtr:id><gtr:title>Comprehensive Metabolic Profiling of Age-Related Mitochondrial Dysfunction in the High-Fat-Fed ob/ob Mouse Heart.</gtr:title><gtr:parentPublicationTitle>Journal of proteome research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8d33cf2ec743344310cadecc6294d895"><gtr:id>8d33cf2ec743344310cadecc6294d895</gtr:id><gtr:otherNames>Wang X</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1535-3893</gtr:issn><gtr:outcomeId>56bb67e6b10902.17832355</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F95BAD00-C672-4571-903E-819CDFAAEBFC</gtr:id><gtr:title>Altered colonic mucosal availability of n-3 and n-6 polyunsaturated fatty acids in ulcerative colitis and the relationship to disease activity.</gtr:title><gtr:parentPublicationTitle>Journal of Crohn's &amp; colitis</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c2a9502c44a9b71d5a8aa8c96eba3aaa"><gtr:id>c2a9502c44a9b71d5a8aa8c96eba3aaa</gtr:id><gtr:otherNames>Pearl DS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1873-9946</gtr:issn><gtr:outcomeId>5461fb52a6fe37.08289072</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1D868141-7551-4018-A357-3B51CADCB060</gtr:id><gtr:title>Genetic Predisposition to an Impaired Metabolism of the Branched-Chain Amino Acids and Risk of Type 2 Diabetes: A Mendelian Randomisation Analysis.</gtr:title><gtr:parentPublicationTitle>PLoS medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/590c8a9618b273cc7c1e0848dd49db27"><gtr:id>590c8a9618b273cc7c1e0848dd49db27</gtr:id><gtr:otherNames>Lotta LA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1549-1277</gtr:issn><gtr:outcomeId>58bd343da4b849.62330961</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EAF22EA7-C604-4A61-8BDC-A94C255D1E61</gtr:id><gtr:title>A metabolomic strategy defines the regulation of lipid content and global metabolism by ?9 desaturases in Caenorhabditis elegans.</gtr:title><gtr:parentPublicationTitle>BMC genomics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/91d7098c12f9ac872ccb48d93bd0b20a"><gtr:id>91d7098c12f9ac872ccb48d93bd0b20a</gtr:id><gtr:otherNames>Castro C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1471-2164</gtr:issn><gtr:outcomeId>EJMprJUh7f2</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>21B627F7-0B0E-42F0-B540-27A48F5C1291</gtr:id><gtr:title>Alterations in endo-lysosomal function induce similar hepatic lipid profiles in rodent models of drug-induced phospholipidosis and Sandhoff disease.</gtr:title><gtr:parentPublicationTitle>Journal of lipid research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/349d34f3d95ccdd4d3b243f5a52b2a3b"><gtr:id>349d34f3d95ccdd4d3b243f5a52b2a3b</gtr:id><gtr:otherNames>Lecommandeur E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0022-2275</gtr:issn><gtr:outcomeId>5a6167ea61afb1.38061514</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>890B8F65-57AF-4E17-A032-80ACD70A587C</gtr:id><gtr:title>Association of Plasma Phospholipid n-3 and n-6 Polyunsaturated Fatty Acids with Type 2 Diabetes: The EPIC-InterAct Case-Cohort Study.</gtr:title><gtr:parentPublicationTitle>PLoS medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5d49fb8098ab21616c9235687213475f"><gtr:id>5d49fb8098ab21616c9235687213475f</gtr:id><gtr:otherNames>Forouhi NG</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1549-1277</gtr:issn><gtr:outcomeId>585d6c1a8ed4c0.35045756</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B7B906A3-6F45-44A7-8999-CB6416CB71CA</gtr:id><gtr:title>Metabolomics As a Tool for the Characterization of Drug-Resistant Epilepsy.</gtr:title><gtr:parentPublicationTitle>Frontiers in neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8d7481c7f2ba302821003c428bb3f651"><gtr:id>8d7481c7f2ba302821003c428bb3f651</gtr:id><gtr:otherNames>Murgia F</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1664-2295</gtr:issn><gtr:outcomeId>5a616e6492fdb9.84767172</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5E83320A-07DA-4E44-A6CA-390D1D5BCAFB</gtr:id><gtr:title>NMR-Based Metabolomics Separates the Distinct Stages of Disease in a Chronic Relapsing Model of Multiple Sclerosis.</gtr:title><gtr:parentPublicationTitle>Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/77ed1262063e9329e3175cc70758d0fa"><gtr:id>77ed1262063e9329e3175cc70758d0fa</gtr:id><gtr:otherNames>Dickens AM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1557-1890</gtr:issn><gtr:outcomeId>56bb67e681c9d2.79638709</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>49D4FEE2-FD00-4611-9442-E042C2B07683</gtr:id><gtr:title>Nox4 reprograms cardiac substrate metabolism via protein O-GlcNAcylation to enhance stress adaptation.</gtr:title><gtr:parentPublicationTitle>JCI insight</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6b7493f394a45072138eaf334a327af8"><gtr:id>6b7493f394a45072138eaf334a327af8</gtr:id><gtr:otherNames>Nabeebaccus AA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>2379-3708</gtr:issn><gtr:outcomeId>5a60dc1e431876.82030297</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>55837577-6B72-4339-930F-4ECDDA4B08BD</gtr:id><gtr:title>Behavioural and molecular endophenotypes in psychotic disorders reveal heritable abnormalities in glutamatergic neurotransmission.</gtr:title><gtr:parentPublicationTitle>Translational psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a5ba4e6bb7aa2ea1d59bd4baac1782c0"><gtr:id>a5ba4e6bb7aa2ea1d59bd4baac1782c0</gtr:id><gtr:otherNames>Scoriels L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>2158-3188</gtr:issn><gtr:outcomeId>56bb67e75847d7.87313151</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>29F2360C-CB40-440A-95D4-A18FF1265A6F</gtr:id><gtr:title>Adipose tissue fatty acid chain length and mono-unsaturation increases with obesity and insulin resistance.</gtr:title><gtr:parentPublicationTitle>Scientific reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/21cb25ff8772b4c914687a805b1d4c64"><gtr:id>21cb25ff8772b4c914687a805b1d4c64</gtr:id><gtr:otherNames>Yew Tan C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>2045-2322</gtr:issn><gtr:outcomeId>56bb5ecbc0e064.89752787</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C9330F29-AEB0-47C1-B7C7-D978A66092E0</gtr:id><gtr:title>Methods for performing lipidomics in white adipose tissue.</gtr:title><gtr:parentPublicationTitle>Methods in enzymology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/59b6e3728c2503ea027017abe00a44c7"><gtr:id>59b6e3728c2503ea027017abe00a44c7</gtr:id><gtr:otherNames>Roberts LD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:isbn>9780128002803</gtr:isbn><gtr:issn>0076-6879</gtr:issn><gtr:outcomeId>pm_53cc044c044e8b5c8</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A6EBF353-8908-4C83-A42F-13207F00A9EE</gtr:id><gtr:title>Targeted metabolomics identifies perturbations in amino acid metabolism that sub-classify patients with COPD.</gtr:title><gtr:parentPublicationTitle>Molecular bioSystems</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/619a8fe02d16d22483cc100d804e6833"><gtr:id>619a8fe02d16d22483cc100d804e6833</gtr:id><gtr:otherNames>Ubhi BK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1742-2051</gtr:issn><gtr:outcomeId>pm_13207_27_23051772</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>07883E52-A450-473F-9A63-B39FBBCD7D52</gtr:id><gtr:title>nmrML: A Community Supported Open Data Standard for the Description, Storage, and Exchange of NMR Data.</gtr:title><gtr:parentPublicationTitle>Analytical chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8ab308e43b78897b525b86b55467451c"><gtr:id>8ab308e43b78897b525b86b55467451c</gtr:id><gtr:otherNames>Schober D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2018-01-01</gtr:date><gtr:issn>0003-2700</gtr:issn><gtr:outcomeId>5a60df9b891417.42791503</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">MC_UP_A090_1006</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>7C58A707-1BF6-4573-A44F-30B271C80813</gtr:id><gtr:percentage>20</gtr:percentage><gtr:text>Cancer</gtr:text></gtr:healthCategory><gtr:healthCategory><gtr:id>D4FDB752-4E9C-491F-9C63-B7D7F6F95417</gtr:id><gtr:percentage>20</gtr:percentage><gtr:text>Cardiovascular</gtr:text></gtr:healthCategory><gtr:healthCategory><gtr:id>160D22D0-5677-4513-A0AC-7F3526B7F336</gtr:id><gtr:percentage>20</gtr:percentage><gtr:text>Metabolic and Endocrine</gtr:text></gtr:healthCategory><gtr:healthCategory><gtr:id>D81A471F-556F-4570-BF6A-5D197943223C</gtr:id><gtr:percentage>20</gtr:percentage><gtr:text>Oral and Gastrointestinal</gtr:text></gtr:healthCategory><gtr:healthCategory><gtr:id>A77DAE3A-499B-4F46-971D-6C82F51F9C2E</gtr:id><gtr:percentage>20</gtr:percentage><gtr:text>Stroke</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>CF950C9A-DB16-4E23-8AEB-94548777BCA1</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>1.1  Normal biological development and functioning</gtr:text></gtr:researchActivity><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>